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Functional residual capacity (FRC) is the gas volume remaining in the lung 
following a normal expiration. The size of the FRC may be compromised as result of 
many pathophysiologic factors, including anesthesia, obesity, acute lung injury, and acute 
respiratory distress syndrome. Without sufficient FRC volume, both blood oxygenation 
and carbon dioxide excretion are limited, leading to hypoxemia, carbon dioxide retention, 
and possible morbidity and mortality. 
Clinicians have long recognized the potential for improved care from FRC 
measurement availability, and researchers have been looking for an effective means of 
bedside FRC assessment during mechanical ventilation for decades. FRC measurement is 
useful, for example, for guiding ventilation management to improve gas exchange for 
patients with reduced FRC. Traditional methods of FRC measurement have been valuable 
for researching disease progression and monitoring ambulatory patients, but are 
impractical at the bedside. Recent research has proposed better bedside utility through 
volume-based methods such as nitrogen or oxygen wash-in/ washout to help address the 
need for FRC measurement. However, the proposed volume-based methods give lower 
measurement precision during ventilation with spontaneous effort or high airway 
pressure. Furthermore, these volume-based systems cannot be used with circle breathing 
systems which are commonly found in the operating room. Thus, the need remains for 
automated, accurate bedside FRC measurement systems that can be used in the intensive 
 iv 
care unit and the operating room during many modes of ventilation, including controlled, 
assisted, spontaneous and mixed. 
This dissertation describes the development, clinical feasibility testing and clinical 
accuracy assessment of two novel bedside models for FRC measurement that use tracer 
gas washin/washout. The first model, called the modified multiple breath nitrogen 
washout model, makes use of end-tidal gas measurements to measure FRC. Using end-
tidal measurements instead of volume reduces errors from signal synchronization. The 
second model, which is called the partial rebreathing carbon dioxide model, allows FRC 
measurement during fixed inspired oxygen concentration, making FRC measurement 
possible in the operating room, where circle breathing systems are common. Both FRC 
measurement methods demonstrate good accuracy, are compatible with any ventilator 
brand and can easily be moved from patient to patient for bedside measurement. 
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Functional residual capacity (FRC), the gas volume remaining in the lungs 
following a normal expiration, has traditionally been difficult to measure at the bedside. 
Maintaining enough FRC volume for sufficient gas exchange, however, is an important 
underlying concern of many ventilation strategies and treatments for patients under 
mechanical ventilation. Currently, surrogate measures such as lung compliance, arterial 
partial pressure of oxygen and carbon dioxide, and pulmonary dead space fraction are 
used to evaluate the effectiveness of treatment strategies aiming to increase the FRC and 
improve gas exchange. Now, new monitoring technology and modern computing 
capacity provide the opportunity to develop an automated bedside FRC measurement 
technique that can be used independently or in conjunction with surrogate measures to 
detect important changes in FRC, guide treatment and improve outcome. This thesis 
proposes novel methods that advance the state of the art for automated, bedside 
measurement of FRC during mechanical ventilation. 
 
1.1 Background and Significance 
The residual gas volume in the lungs following normal expiration is called 
functional residual capacity (FRC). The primary role of the FRC is to buffer against large 
intrabreath changes in the partial pressure of oxygen in the alveoli (PAO2), thereby 
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providing ample oxygen for blood oxygenation. FRC volume is not actively regulated; it 
is determined by the passive mechanical relationship between the chest wall and the 
lungs. 
In both resting and exercising healthy individuals, the FRC volume is 
approximately 2.2 liters.1 During anesthesia, FRC is reduced by about 20% in normal 
patients, and 85-90% of all adults develop collapsed lung tissue during anesthesia.2 In 
morbidly obese patients or patients with chronic obstructive lung disease (COPD), FRC 
is reduced by as much as 50%3 in anesthesia. A reduction in FRC leads to compression 
atelectasis, an increased ventilation/perfusion (V/Q) mismatch, and ultimately an increase 
in the alveolar-arterial oxygen gradient. Postoperatively, FRC is also reduced, and has 
been associated with postoperative hypoxemia, atelectasis, and pneumonia. Reduced FRC 
is also a contributor to postoperative morbidity and mortality.4 With compromised FRC 
volume, the mean PAO2 is lower and the intrabreath changes in PAO2 are larger, resulting 
in reduced availability of oxygen for the pulmonary capillary blood. Furthermore, a small 
FRC reduces the potential for removal of carbon dioxide from the body. With a smaller 
FRC, the mean PACO2 is higher and the intrabreath changes in PACO2 are larger, 
resulting in reduced capacity for removal of carbon dioxide from the blood.  
Collapsed alveolar lung tissue can be re-expanded in healthy lungs with a vital 
capacity maneuver2 and can be re-recruited with recruitment maneuvers and increased 
positive end-expiratory pressure (PEEP).4 If the FRC is increased too much, however, the 
lungs may become injured and the cardiac output may be reduced. Assessment and 
tracking of FRC is critical in patients with lung disease, such as Acute Lung Injury (ALI) 
and Acute Respiratory Distress Syndrome (ARDS), which is often accompanied by 
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refractory hypoxemia, decreased lung compliance, and an acute decrease in FRC.5 FRC 
has long been recognized as a key parameter for treating hypoxemic patients.6 FRC is 
also useful for scaling delivered tidal volume to measured, injured lung size rather than to 
a predicted, larger, healthy lung size during mechanical ventilation.7 Access to bedside 
FRC measurement in clinical practice, however, remains limited.  
Conventional techniques for measuring FRC include washout/wash-in methods, 
dilution methods, and body plethysmography.8-12 These methods have been widely used 
for research, but not for routine clinical practice in the intensive care unit because they 
are complicated, expensive, may require manual intervention and patient cooperation, 
and are cumbersome to use during mechanical ventilation.13-16  For example, East9 
developed an automated sulfur hexafluoride (SF6) method for use during mechanical 
ventilation. Although the method was accurate and capable of bedside measurements, a 
commercial product was never released because of the requirement for injection of a 
special tracer gas into the breathing circuit.  
Body plethysmography FRC measurement, which is based on Boyle’s law (that 
the volume of gas varies in inverse proportion to the pressure applied under constant 
temperature), is highly accurate, precise and repeatable.12 Two pressure sensors (one at 
the box wall and one at the mouthpiece) are used in conjunction with the known box 
volume to measure the FRC volume of the subject as they pant gently at end-expiration 
(FRC) against a closed shutter. The FRC volume measured by body plethysmography 
includes all intrathoracic gas. While body plethysmography is the gold standard for 
ambulatory patients and has been used in anesthetized patients,11,17 the requirement of 
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placing the subject in a rigid box makes the method too burdensome and difficult to use 
during mechanical ventilation.  
Nitrogen washout with an open circuit method has been under investigation for 
FRC measurement since 1940.8 To initiate a measurement, the inspired fraction of 
oxygen is changed from baseline to 1.0 to wash out all nitrogen from the lungs. The total 
volume of nitrogen inspired and expired with each breath and the change in end-tidal 
nitrogen concentration are recorded during the washout measurement. The inspired 
fraction of oxygen is then returned to baseline and the volume and concentration changes 
of nitrogen are again measured as nitrogen washes back into the lungs. Nitrogen washout 
measures the volume of the FRC which is in communication with ventilation, but it does 
not measure “trapped gas,” where airway closure prohibits washout. Recent 
simplifications and refinements of the measurement technique have improved the utility 
of the nitrogen washout method for bedside monitoring during mechanical 
ventilation.15,18 GE Healthcare has introduced a FRC measurement method as an optional 
software package (FRC INview, GE Healthcare, Madison, WI) for one of their ventilators 
(Engstrom Carestation, GE Healthcare, Madison, WI). While the nitrogen washout/wash-
in method has been shown to be accurate during stable, controlled mechanical 
ventilation,18 it has not yet been demonstrated as accurate or precise during assisted 
mechanical ventilation. The expensive requirement of using a specific ventilator for FRC 
measurement may also limit widespread clinical adoption of the method.  
The difficulty of FRC measurement at the bedside has previously been a 
limitation to the wider use of FRC measurements, especially during the evolution and 
treatment of acute lung injury.19 As some have suggested,14 the cost and complexity of 
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current FRC techniques may conventionally be considered too high in view of the 
relative simplicity of surrogate measures such as airway compliance or blood gas 
measurements. Thus, there remains a need for an automated, inexpensive, bedside FRC 
measurement method that is accurate, precise and repeatable throughout the uneven 
breath patterns typically found during assisted mechanical ventilation, as well as in all 
modes of ventilation, including controlled, spontaneous and mixed. There is also a need 
for a FRC measurement system that can be used with circle breathing systems that are not 
capable of creating a step change in inspired oxygen fraction and for patients in whom a 
step change in inspired oxygen cannot be tolerated at all, such as patients requiring a high 
inspired oxygen fraction to maintain arterial blood oxygen saturation. 
Two gases commonly found in air can be readily used as the tracer gas for an 
automated, stand-alone FRC measurement system: nitrogen and carbon dioxide. 
Nitrogen-based FRC measurement systems have been the most extensively investigated, 
with the earliest system being developed in 1940.8 Nitrogen is a suitable choice as a 
tracer gas because of its low blood solubility. It is also relatively simple to achieve a large 
change in inspired nitrogen concentration for a reliable FRC measurement by increasing 
the fraction of inspired oxygen. The largest possible change for inspired nitrogen is a 
change from approximately 79% to 0% nitrogen, which can be achieved by increasing the 
inspired oxygen from 21% to 100%. After ventilation for several minutes with 100% 
inspired oxygen, for example, all nitrogen originally in the lung is washed out. Large 
changes in nitrogen concentration produce a large signal to noise ratio and the possibility 
for accurate, precise and repeatable FRC measurements, even during assisted mechanical 
ventilation during which breath patterns and volumes are often irregular. A nitrogen-
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based FRC measurement is compatible with any ventilator that can quickly alter inspired 
oxygen fraction, and it does not require the addition of other gases or bulky equipment. 
Like all washout FRC measurements, the nitrogen-based FRC measurement accounts for 
the ventilated alveoli, including the portion of the alveoli that are more poorly ventilated, 
but not the “trapped gas.” With a high signal to noise ratio and the ability to measure the 
ventilated, “communicating,” FRC at the bedside, a nitrogen-based measurement system 
demonstrates the accuracy and precision necessary to support spot checking the FRC 
volume with one or two individual measurements. A nitrogen-based system is simple to 
use and can readily be automated. 
Carbon dioxide has also been investigated as a tracer gas for FRC measurement 
even though it is highly soluble in blood and tissue.20 If solubility is properly accounted 
for, carbon dioxide may have advantages over nitrogen for FRC measurement in several 
application areas. First, unlike nitrogen, a carbon dioxide-based FRC measurement 
system does not require a step change in inspired oxygen and can therefore be used for 
patients who cannot tolerate such a change in inspired oxygen concentration. Second, 
circle breathing systems commonly used in the operating room are not capable of 
creating the step change in inspired oxygen needed for the nitrogen FRC measurement. A 
carbon dioxide-based system is compatible with any type of ventilator and many inhaled 
anesthetics. Third, the carbon dioxide-based FRC measurement is readily automated for 
use during mechanical ventilation since the measurement signal can be initiated by a 
monitor (NICO2, Philips Medical, Wallingford, CT) that makes use of a partial 
rebreathing system to noninvasively estimate pulmonary capillary blood flow and cardiac 
output. The partial rebreathing system induces a small change in the partial pressure of 
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end-expired CO2 for 35 seconds once every three minutes. The maximum change 
observed in the CO2 signal is approximately 4 mmHg, which is roughly a 9-12% change 
from baseline. It may therefore be possible to use the small, observed change in CO2 
during the washout at the end of rebreathing to estimate the FRC in addition to the 
cardiac output during stable, controlled mechanical ventilation. 
 
1.2 Research Contributions 
This dissertation develops and investigates the clinical feasibility, accuracy and 
repeatability of two novel methods (based on nitrogen and carbon dioxide) for measuring 
FRC at the bedside during mechanical ventilation. The novel nitrogen-based method 
relies on a model of the change in concentration of nitrogen within the lung rather than on 
a measurement of nitrogen volume expired and inspired with each breath during FRC 
measurement, as traditional methods do. The carbon dioxide-based washout method is 
extended to include a correction for carbon dioxide solubility in simultaneously measured 
pulmonary capillary blood flow. As stated in the previous section, there are advantages 
and disadvantages of each tracer gas method, so we chose to develop and clinically assess 
both methods in parallel during the course of this research. Each of the novel methods 
requires input parameters derived breath-by-breath from the flow and gas concentration 
signals to calculate FRC. The first step of development for both methods identified the 
best means of obtaining the input parameters for the FRC measurement. Of the input 
parameters in question, airway dead space volume is frequently estimated based on body 
weight, and we considered using the dead space estimate rather than the measured value 
obtained from each breath. We evaluated the accuracy of the estimate because it is 
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important for calculating the alveolar ventilation for each breath, another parameter 
required for FRC measurement.  
To test clinical feasibility, both nitrogen- and carbon dioxide-based tracer gas 
methods evaluated changes in FRC subsequent to changes in mechanical ventilator 
settings and lung injury in an animal model. In clinical testing, accuracy and precision 
were first established by comparing the two systems to the gold standard body 
plethysmography. There is no gold standard for FRC measurement during mechanical 
ventilation, and therefore individual measurements from both systems were then assessed 
for repeatability in intensive care patients. The nitrogen system further served as a 
surrogate gold standard for the carbon dioxide system during mechanical ventilation. All 
clinical data were analyzed retrospectively during model development to ensure the 
systems were reliable across all types of study subjects. 
Research contributions of this work include: 1) A confirmation that a body 
weight-based estimate of anatomic dead space is not a good substitute for volumetric 
capnography-derived dead space measurements used for real-time calculation of alveolar 
tidal volume, 2) a multiple-compartment model of the lung that describes the multiple 
breath nitrogen washout curves resulting from a step change in inspired oxygen and a 
clinical assessment of the accuracy of the resulting FRC measurements, 3) evaluation of a 
novel, on-airway fast oxygen sensor for a novel application of FRC measurement and 4) 
an extension of the method for FRC assessment using carbon dioxide as the tracer gas 
during mechanical ventilation and a clinical study of the accuracy of the FRC 
measurements. The automated bedside measurement of FRC is promising for both 
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methods, provided future testing shows accuracy is clinically acceptable for patients with 
significant lung injury. 
This dissertation is organized as follows: Chapter 2 examines patient respiratory 
and demographics data and demonstrates that real-time measurements of anatomic dead 
space are required in favor of equation-based predictions for accurate alveolar ventilation 
measurement. Both parameters are needed in the models to calculate FRC. Chapter 3 
investigates the feasibility of two tracer gas methods for FRC determination during 
mechanical ventilation for animals with both healthy lungs and an oleic acid model of 
acute lung injury. The FRC measurements of both methods track changes in positive end-
expiratory pressure even during lung injury, indicating measurement is possible during 
mechanical ventilation. Chapter 4 investigates the accuracy, precision and repeatability of 
the modified multiple breath nitrogen washout FRC model in healthy, spontaneously 
breathing volunteers and also in intensive care patients whose lungs are mechanically 
ventilated. FRC measurements are accurate and repeatable, even during variable 
ventilation patterns, and the precision is improved compared to other published methods. 
Chapter 5 assesses the accuracy, precision and repeatability of the partial carbon dioxide 
rebreathing FRC method during steady ventilation patterns in healthy volunteers and also 
in intensive care patients whose lungs are mechanically ventilated. The observed 
accuracy indicates automated bedside measurement during controlled mechanical 
ventilation may be possible with the partial carbon dioxide rebreathing method; 
automation makes it feasible to trend FRC values for hours or days. Each of these 
chapters has been published, accepted for publication, or submitted for publication. 
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Finally, Chapter 6 summarizes conclusions from this work and suggests future work in 
this area of research. 
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Anatomic dead space (also called airway or tracheal dead space) is the part of the 
tidal volume that does not participate in gas exchange. Some contemporary ventilation 
protocols, such as the Acute Respiratory Distress Syndrome Network protocol, call for 
smaller tidal volumes than were traditionally delivered. With smaller tidal volumes, the 
percentage of each delivered breath that is wasted in the anatomic dead space is greater 
than it is with larger tidal volumes. Many respiratory and medical textbooks state that 
anatomic dead space can be estimated from the patient’s weight by assuming there is 
approximately 1 mL of dead space for every pound of body weight. With a volumetric 
capnography monitor that measures on-airway flow and CO2, the anatomic dead space 
can be automatically and directly measured with the Fowler method, in which dead space 





2.1.2 Methods  
We analyzed data from 58 patients (43 male, 15 female) to assess the accuracy of 
5 anatomic dead space estimation methods. Anatomic dead space was measured during 
the first 10 min of monitoring and compared to the estimates. 
 
2.1.3 Results  
The coefficient of determination (r2) between the anatomic dead space estimate 
based on body weight and the measured anatomic dead space was r2 = 0.0002. The mean 




It appears that the anatomic dead space estimate methods were sufficient when 
used (as originally intended) together with other assumptions to identify a starting point 
in a ventilation algorithm, but the poor agreement between an individual patient’s 
measured and estimated anatomic dead space contradicts the assumption that dead space 
can be predicted from actual or ideal weight alone.  
 
2.2 Introduction 
The anatomic dead space (also called airway, tracheal, or series dead space) is the 
part of the tidal volume (VT) that remains in the conducting passages at the end of 
inspiration and therefore does not participate in gas exchange. During expiration the gas 
from the conducting passages has the same composition as it did in inspiration; it is 
commonly referred to as wasted ventilation. Anatomic dead space was first measured 




dead space measurement technique using a rapid CO2 analyzer, and in 1954 Bartels et al3 
found that several indicator gases, including oxygen and carbon dioxide, all gave the 
same value for anatomic dead space and could therefore be used interchangeably.  
Many current textbooks4-7 suggest a simple method of estimating anatomic dead 
space based on the patient’s body weight or predicted body weight. Specifically, they 
suggest that anatomic dead space is approximately 1 mL per pound of body weight. 
Because this dead space estimation technique has been so widely disseminated, many 
clinicians apply the 1 lb = 1 mL rule in clinical practice.   
The observation that anatomic dead space is roughly correlated with body weight 
seems to have been first put forth by Radford8 in 1955. Radford’s article described 
ventilation standards he had developed to predict an individual’s required ventilation 
based on their body weight and sex. As part of the development of the ventilation 
standard, he presented anatomic dead space data and estimated dead space values for 11 
patient groups that comprised 131 subjects, ages newborn to 59.6 ± 6.3 y, mean body 
weight range 8-170 lb. Radford plotted the mean dead space as a function of the mean 
body weight for each one of the 11 groups, and observed a “remarkable, but approximate, 
rule that the respiratory dead space in milliliters (at body temperature and pressure 
saturated) equals the body weight in pounds.” 
Contemporary ventilation protocols such as that of the Acute Respiratory Distress 
Syndrome (ARDS) Network,9 which call for smaller VT as part of a lung-protection 
strategy for patients with ARDS or acute lung injury, result in a larger percentage of each 
breath being wasted in the anatomic dead space volume, compared to ventilation with 




assumed alveolar minute ventilation may be much smaller or larger than the actual 
alveolar minute volume, which can lead to unintentional hypoventilation if the dead 
space estimate is too small, or an unintentionally large alveolar VT if the dead space 
estimate is too large. Unintentional hypoventilation could be made worse by a breathing 
circuit that includes excessive apparatus dead space.10,11  
Anatomic dead space can be calculated with the Fowler equal-area method, which 
is based on volumetric capnography.1 We analyzed data collected with a respiratory 
profile monitor that provides volumetric CO2 analysis, to study how well the estimated 
anatomic dead space predicted the measured anatomic dead space in a group of 
mechanically ventilated patients. 
 
2.3 Methods 
The study was performed at the University of Utah Health Sciences Center. The 
study was approved by our investigational review board, and informed consent was not 
required.  We analyzed data from 58 patients (43 male, 15 female) who were tracheally 
intubated, mechanically ventilated and sedated, in either the operating room (42 patients) 
or the intensive care unit. (16 patients), who had been admitted for coronary artery bypass 
graft or valve repair surgeries. The data set had been previously collected to measure end-
tidal CO2, carbon dioxide production, and Fick cardiac output. Mean ± standard deviation 
patient characteristics included: age 63.2 ± 13.8 y (range 14-81 y), body weight 188 ± 42 
lb (range 110 – 301 lb), height 172.9 ± 9.8 cm (range 149-198 cm), predicted ideal body 





The patients were monitored with a volumetric CO2 monitor that has a 
combination CO2 and flow sensor (NICO2, Respironics, Wallingford CT). This monitor 
calculates anatomic dead space on a breath-to-breath basis, by analyzing the expiratory 
volume at which the CO2 signal transitions from anatomic to alveolar CO2, using the 
Fowler method1 (Figure 2.1). For each patient the mean anatomic dead space was 
measured with data collected during the first 10 min of monitoring and compared to the 
values predicted by five published prediction methods,8,12-16 which are based on actual 
body weight or ideal body weight and an allowance for the presence of an endotracheal 
tube (ETT). 
In 21 patients there was an elbow placed in the breathing circuit between the ETT 
and the volumetric capnometry sensor. With those patients we subtracted a volume of 6 
mL from the measured anatomic dead space, to compensate for the dead space added by 
the elbow. For all other patients the ETT was connected directly to the volumetric 
capnometry sensor, so no compensation was required. 
The most frequently published anatomic dead space prediction equation is cited in 
many general and respiratory physiology texts.4-7 This method was published by Radford8 
and simply states that 1 lb of actual body weight corresponds to 1 mL of anatomic dead 
space. A second, commonly used method, published by Nielsen,12 uses the ideal body 
weight, based on the patient’s height: 
 
1 mL of dead space = 1 lb of ideal body weight. [2.1] 
 
Ideal body weight is calculated as: 
 




Figure 2.1: Volumetric capnogram depicting the derivation of anatomic and 
alveolar dead space. Anatomic, or airway, dead space is identified as the vertical line that 
bisects the rise on the capnogram during exhalation. Alveolar dead space is identified by 






for females, and 
 
50 + (0.91 x (height in cm - 152.4)) x 2.2046 [2.3]  
 
for males.9,13 
A refinement by Nunn and Hill14 of the 1 mL = 1 lb method states that estimated 
anatomic dead space should be decreased by 72 mL if the patient is intubated, to account 
for the extrathoracic volume bypassed by the ETT:  
 
1 mL = 1 lb actual body weight - 72 mL. [2.4] 
 
Casati et al15 proposed reducing the estimate of 1 lb = 1 mL by 50% to account 
for the volume bypassed by the airway-maintenance devices: 
 
1 mL = 0.5 x 1 lb of actual body weight. [2.5] 
 
The Suwa and Bendixen method16 uses a similar, related approach that estimates 
dead space as two thirds of the patient’s weight:  
 
1 mL = 0.66 x 1 lb of actual body weight.  [2.6] 
 
We used spreadsheet software (Excel, Microsoft, Redmond, Washington) to 
conduct the linear regression analysis and to calculate all statistics. The mean and 
standard deviation were calculated for respiratory rate, number of dead space 
measurements, VT (mL, mL/kg ideal body weight, and mL/kg measured body weight), 
positive end-expiratory pressure (PEEP), inspiratory time, measured anatomic dead 




calculated the coefficient of determination (r2), mean bias ± 95% confidence interval 
(CI), standard deviation of the bias, and limits of agreement (mean bias ± 2 standard 
deviation) ± CI between the measured and estimated values.17 For 2 methods to be used 
interchangeably, we defined clinically acceptable mean bias and limits of agreement to be 
small enough that the estimation allowed the patient to be ventilated within 10% of the 
intended delivered ventilation. For each method we also calculated the ratio of the mean 
measured anatomic dead space to predicted anatomic dead space. 
 
2.4 Results 
Figure 2.2 illustrates the regression analysis for measured anatomic dead space 
versus ideal body weight. The r2 for the regression of the measured and predicted 
anatomic dead space was 0.0002 for each prediction method except the Nielsen method, 
which had r2 of 0.058.  
Figure 2.3 illustrates the Bland-Altman analysis for the Suwa method, which was 
the method with the lowest bias.  
Table 2.1 reports the r2 values, mean bias, standard deviation of the bias and 
limits of agreement for the five methods. When we used the ideal body weight instead of 
actual body weight in the Nunn, Casati, and Suwa methods, the r2 was 0.058 (Table 2.2). 
The mean and standard deviation of the measured anatomic dead space were 
calculated for each patient. The mean measured anatomic dead space was 128 mL, and 
the mean intrapatient standard deviation of the measurements was 4.3 mL (range 1.2– 8.7 
mL). Table 2.3 shows the measured and calculated respiratory variables. 
The ratio of mean measured anatomic dead space to mean predicted anatomic 
dead space was 1:1.10 with Nunn’s classic method (actual weight - 72 mL), and 1:1.7 for 
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Table 2.1. Results From 5 Methods of Estimating Anatomic Dead Space 
Method* r2 Mean Bias (mL) 95% CI  of Bias (mL) SD Bias (mL) Limits of Agreement 
Radford8 0.0002 59.9 45.7 to 74.1 53.9 –45.7 to 165.5 
Nielsen12 0.058 20.9 11.5 to 30.3 35.9 –49.5 to 91.3 
Nunn13 0.0002 –12.1 –26,3 to 2.1 53.9 –117.7 to 93.5 
Casati14 0.0002 –34.1 –44.5 to –23.7 39.7 –111.9 to 43.7 
Suwa15 0.0002 –2.7 –14.2 to 8.8 43.8 –88.6 to 83.1 
* Methods: 
Radford: anatomic dead space in mL = weight in pounds 
Nielsen: anatomic dead space in mL = ideal weight in pounds 
Nunn: anatomic dead space in mL = weight in pounds – 72 mL 
Casati: anatomic dead space in mL = 0.5 × weight in pounds 
Suwa: anatomic dead space in mL = 0.66 × weight in pounds 




Table 2.2. Results From 3 Methods of Estimating Anatomic Dead Space Using Ideal 
Body Weight Rather Than Actual Weight 
Method* r2 
Mean Bias 
(mL) 95% CI  of Bias (mL) SD Bias (mL) 
Limits of 
Agreement 
Nunn 0.058 –51.1 –60.5 to –41.7 35.9 –121.5 to 19.3 
Casati 0.058 –53.6 –62.3 to –44.9 33.0 –118.3 to 11.1 
Suwa 0.058 –28.7 –37.5 to –19.9 33.6 –94.6 to 37.1 
* Methods: 
Nunn: anatomic dead space in mL = ideal weight in pounds – 72 mL 
Casati: anatomic dead space in mL = 0.5 × ideal weight in pounds 
Suwa: anatomic dead space in mL = 0.66 × ideal weight in pounds 
CI = confidence interval 




Table 2.3. Respiratory Variables 
Variable Mean ± SD 
Respiratory rate (breaths/min) 10.3 ± 2.3 
Measurements per subject 103.5 ± 23.0 
VT (mL) 770.8 ± 193.7 
VT (mL/Kg ideal weight) 11.5 ± 2.6 
VT (mL/Kg actual weight) 9.3 ± 2.5 
PEEP (cmH2O) 2.3 ± 2.0 
Inspiratory time (s) 1.9 ± 0.5 
Dead Space (mL)  
        Measured 128.0 ± 33.8 
        Radford method 187.9 ± 42.3 
        Nielsen method 148.9 ± 22.7 
        Nunn method 115.9 ± 42.3 
        Casati method 94.0 ± 21.2 
        Suwa method 125.3 ± 28.2 





the method ideal body weight - 72 mL. The ratios that were the closest to 1:1 were the 
Suwa method (1:1.02, with actual weight) and the Nielsen method (1:1.29). 
 
2.5 Discussion 
The poor correlation in the present data set between patient weight and measured 
anatomic dead space appears to conflict with the common practice of estimating anatomic 
dead space from body weight. Generally, it appears that the mean anatomic dead space in 
milliliters corresponds to the mean body weight in pounds for the overall population, 
since the line of identity passes through the data cluster. However, based on the 
variability of the measured values in our data for a given weight or ideal weight, there is 
no basis for estimating an individual patient’s anatomic dead space volume from the body 
weight or ideal body weight. The Bland-Altman analysis, with both mean bias and limits 
of agreement, confirms that estimation and measurement are not interchangeable 
methods. Even if we had defined clinically acceptable mean bias and limits of agreement 
to be within 25% of the intended minute ventilation, for a VT of 330 mL (121 lb person 
ventilated with 6 mL/kg), none of the estimates of anatomic dead space could have been 
used interchangeably with the measurement. 
We also repeated the Bland-Altman analyses on log-transformed data to give the 
methods the best possible chance to agree. The repeated analysis did not change our 
conclusion that the methods are not interchangeable. Bear in mind that the standard 
deviation values in Table 2.3 for each of the dead space estimation methods are 
representative of the range of heights and weights observed in this data set. A limitation 
of our study is that we obtained measurements from a relatively small number of patients. 




In Radford’s original paper,8 which proposed the 1 lb = 1 mL rule, the anatomic 
dead space was plotted as a function of body weight. On his plot the error bars indicate 
that the standard deviation of the anatomic dead space measurements was approximately 
40 mL, which is similar to what we observed with the Radford method. Radford 
emphasized that the rule of 1 mL dead space per pound of body weight gives only a 
rough approximation of anatomic dead space, as evidenced by the large standard 
deviations of the data he presented. He warned that it is probably not justifiable to extend 
the dead-space-to-bodyweight relationship to patients who weigh more than 200 lb. 
Radford also elected to ignore the evidence that anatomic dead space increased with age, 
for the purpose of his ventilation guidelines, because it was a small effect and was offset 
by the decreased carbon dioxide production with age. In fact, Radford did not advocate 
the use of a dead space estimate for anything but a way to simplify the ventilation 
guidelines he was proposing. It appears that the practice of estimating dead space from 
body weight has become a matter of convenience, but it was not Radford’s intended 
message. His proposed ventilation guidelines, on the other hand, have stood the test of 
time and are still in wide use today as a starting point for setting automatic support 
ventilation and weaning protocols.18,19 
Radford’s ventilation nomogram, which was based on body weight, sex, and 
breathing frequency, required adjustment for the change in anatomic dead space 
associated with endotracheal intubation. For intubated patients he recommended a rough 
correction of subtracting from the total VT a volume corresponding to half the body 
weight. This was based on the observation that the volume of the oronasal dead space and 




Clearly, Radford did not intend the approximate 1:1 correlation between weight and 
anatomic dead space in the overall population to be used as an independent estimate of an 
intubated patient’s anatomic dead space. 
Anatomic dead space is not a fixed value for each individual; it is influenced by 
several factors, most importantly, position of the neck and jaw, anesthesia, drugs that act 
on the bronchiolar musculature, and ventilator settings.4 These factors are likely to 
change during a ventilated patient’s hospital stay, which supports repeated measurement 
rather than a one-time estimation of the anatomic dead space. 
Precise knowledge of the anatomic dead space is more important with a smaller 
VT, as in the ARDS Network ventilation recommendations.9 The percentage of each 
breath lost to anatomic dead space ventilation increases as the VT decreases. As an 
example, consider the average patient in our data set, who weighed the predicted 149 lb. 
With the ARDS Network protocol of 6 mL/kg ideal body weight, the VT would be set to 
406 mL. Our mean measured anatomic dead space was 128 mL, so 32% of every breath 
would be lost to dead-space ventilation. If VT were set at 12 mL/kg, only 16% of each 
breath would be lost to dead space. 
The Nunn method (ideal body weight) had a mean bias of -51.1 mL, compared to 
the measured value. If the average subject in our data set had been ventilated at 6 mL/kg 
ideal body weight, the measured alveolar VT would have been 15% smaller than the 
estimate. If a clinician were to use the estimated rather than the measured dead space 
value, a respiratory rate of 20 breaths/min (minute ventilation of 8 L/min) could 
unintentionally lead to hypoventilation, because the alveolar minute ventilation would be 




The mean bias results from each of the estimation methods reveal that the 
effective alveolar ventilation can be greater or less than expected if the patient-to-patient 
variation in anatomic dead space is not considered. In other words, if two patients with 
the same height, weight, and metabolic rate had different anatomic dead space volumes, 
the same ventilation protocol could yield different PaCO2 values simply because their 
effective alveolar ventilations were different. 
In the present study the mean clinician-selected VT was 11.5 ± 2.6 mL/kg of ideal 
body weight (see Table 2.3). We performed a linear regression analysis of the differences 
between the estimate methods and the measured dead space versus VT in mL/kg ideal 
body weight. The r2 range was 0.017 - 0.16, which correspond to p values (for r) of 0.33 
and 0.002, respectively. For actual VT the r2 range was 0.0016 - 0.077, which correspond 
to p values (for r) of 0.77 and 0.035, respectively. Therefore, in the present data set, we 
observed a range of very small r2 values, with a range of no association to weak statistical 
association for the relationship between the VT size and the measurement error of the 
estimates. 
We also analyzed the influence of outliers on ventilation settings. The r2 for 
measured dead space and VT (mL/kg ideal weight) was originally 0.06, and it was 0.005 
after outliers were removed. Similarly, when outliers of inspiratory time were removed, r2 
decreased from 0.19 to 0.12. We had previously tested the effect of PEEP on anatomic 
dead space and found a strong correlation between increased PEEP (from 0 cm H2O to 20 
cm H2O) and increased measured anatomic dead space, but in the present data set, which 




Quantification of physiologic dead space is clinically important. Nuckton et al 
observed that an increased dead space fraction (VD/VT) is independently associated with 
mortality in patients with ARDS.21 Unfortunately, that study reported only the total 
pulmonary dead space, so it is not possible to reanalyze their results to separate anatomic 
dead space and alveolar dead space. In a subsequent paper, Kallet et al22 found that 
patients with ARDS who had lower VD/VT had a better survival rate: the difference in 
VD/VT between survivors and nonsurvivors was about 0.1. A large proportion of the total 
dead space is anatomic dead space. Our data show that when the contribution of the 
variability in the anatomic dead space is considered, the VD/VT can change by ± 0.13 
solely because of patient-to-patient differences in anatomic dead space. This means that 
the variability in anatomic dead space contributes to VD/VT measurements by a similar 
magnitude as the difference observed between survivors and nonsurvivors. It is likely that 
the prognostic value of VD/VT measurements is related to ventilation-perfusion mismatch 
and not to the percent of each breath lost in anatomic dead space. However, if anatomic 
dead space variability is not considered, then the relationship between VD/VT and 
ventilation-perfusion mismatch is weakened. 
Consider a patient with a low VD/VT and an abnormally small anatomic dead 
space. Based on the VD/VT this patient might be considered to have a favorable 
prognosis, when in fact serious ventilation-perfusion mismatch problems are masked by 
the small anatomic dead space. The solution proposed by Moppett et al23 is to calculate 
the ratio of alveolar dead space to alveolar VT, rather than the total VD/VT. That is, 
measure the anatomic dead space, then subtract the anatomic dead space from both the 




ratio of alveolar dead space to alveolar VT. Moppett et al speculated that the association 
Nuckton21 and Kallet22 observed between dead space ratio and mortality was probably 
due to disturbed ventilation-perfusion matching, and that the alveolar dead space ratio 
would be even more strongly associated with mortality. Drummond and Fletcher24 
pointed out that right-to-left shunting (intrapulmonary or intracardiac) affects the total 
dead space measurement, but not the anatomic dead space measurement. The idea of 
measuring anatomic dead space to estimate the uniformity of alveolar ventilation goes 
back to 1944.25-28 We suggest the use of direct anatomic dead space measurement in 
future studies, to develop better descriptions of the changes that occur in the alveolar 
dead space with lung injury. 
It is important to ensure that the patient receives adequate VT by minimizing 
unnecessary apparatus dead space.[10,11] Apparatus dead space affects both alveolar VT 
and VD/VT, and Nuckton21 and Kallet22 ensured their VD/VT analyses were carried out 
with minimal apparatus dead space. Correct assessment of the effect of all series dead 
space (anatomic and apparatus) requires calculating the apparatus dead space and adding 
that volume to the estimated anatomic dead space. Direct measurement with volumetric 




All these issues point to the need to use direct measurements of anatomic dead 
space, rather than estimation. The errors associated with estimations are less important 
with a larger VT, but with a smaller VT the percentage of each breath lost to anatomic 
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3.1.1 Background  
Several techniques for measuring the functional residual capacity (FRC) of the 
lungs in mechanically ventilated patients have been proposed, each of which is based on 
either nitrogen wash-out or dilution of tracer gases. These methods are expensive, 
difficult, time-consuming, impractical, or require an intolerably large change in the 
fraction of inspired oxygen. We propose a CO2 wash-in method that allows automatic and 
continual FRC measurement in mechanically ventilated patients. 
 
3.1.2 Methods 
We measured FRC with a CO2 partial rebreathing technique, first in a mechanical 
lung analog, and then in mechanically ventilated animals, before, during, and subsequent 
to an acute lung injury induced with oleic acid. We compared FRC measurements from 
partial CO2 rebreathing to measurements from a nitrogen wash-out reference method. 
Using an approved animal protocol, general anesthesia was induced and maintained with 




breathing circuit between the endotracheal tube and the Y-piece. The partial CO2 
rebreathing signal obtained from the monitor was used to calculate FRC. FRC was also 
measured with a nitrogen wash-out measurement technique. In the animal studies we 
collected data from healthy lungs, and then subsequent to a lung injury that simulated the 
conditions of acute lung injury/acute respiratory distress syndrome. The injury was 
created by intravenously infusing 0.09 mL/kg of oleic acid over a 15-min period. At each 
stage of the experiment, the positive end-expiratory pressure (PEEP) was set to 0, 5, 10, 
or 15 cm H2O. At each PEEP level we compared the average of 3 CO2 rebreathing FRC 
measurements to the average of three nitrogen wash-out reference measurements. We 
also tested the FRC measurement system with a mechanical test lung in which the true 
FRC could be directly measured.  
 
3.1.3 Results  
The squared correlation for the linear regression between CO2 rebreathing and 
nitrogen wash-out measurements in the animals was r2 = 0.89 (n = 50). The average error 
of the CO2 wash-out system was -87 mL and the limits of agreement were ± 263 mL. In 
the mechanical test lung, the average error of the FRC measured via the CO2 wash-in 
system was 37 mL, and the limits of agreement were ± 103 mL, which was equivalent to 
1.7% of the true FRC. The squared correlation was r2 = 0.96.  
 
3.1.4 Conclusion  
These results indicate that FRC measurement via CO2 rebreathing can reliably 
detect an FRC decrease during lung injury and can reflect the response of the FRC to 






Measurement of the functional residual capacity (FRC) of the lung via computed 
tomography is a sensitive indicator of decreased aeration and increased consolidation 
during the progression of acute respiratory distress syndrome (ARDS) and acute lung 
injury (ALI), as well as the reversal of the compromised state following appropriate 
ventilator treatment.[1–2] Suter et al[2] found that the highest FRC coincides with 
maximum oxygen transport and the highest static compliance at a specific positive end-
expiratory pressure (PEEP). Hedenstierna[3] concluded that FRC measurement is critical 
for finding optimal ventilator settings.  
As a surrogate for direct measurement of FRC in ventilated patients, some studies 
have pointed to the use of lung mechanics, including the static pressure-volume curves 
and the measurement of the upper and lower inflection points of the alveolar pressure-
volume curve, to guide ventilator settings.[4] However, mechanics-based measurements 
have proven difficult to use for guiding ventilator settings,[5] because aeration of the 
injured lung is dynamic and heterogeneous.[6] Direct measurement of FRC could allow 
ventilation to be set by volume rather than by pressure.  
Although computed tomography has been useful for determining the 
pathophysiology and progression of ARDS/ ALI and for demonstrating the usefulness of 
the FRC measurement to actively control lung volume during mechanical ventilation, the 
method is regarded as risky and cumbersome to use regularly at the bedside for 
monitoring the evolution of lung injury and the effects of the ventilatory strategy. Several 
other techniques for FRC measurement in mechanically ventilated patients have been 




dilution of tracer gases. The techniques include closed-circuit helium dilution,[7,8] open-
circuit nitrogen wash-out,[9–11] and open-circuit sulfur hexafluoride wash-out.[12,13] 
Additionally, FRC has been estimated via electrical impedance tomography[14] and a 
single-breath-hold Fick method.[15] These methods are expensive, difficult and time 
consuming at the bedside, impractical for continual use, or require an intolerably large 
change in the fraction of inspired oxygen (FIO2 ) to complete the measurement.  
We propose here a CO2 wash-in method that allows automatic and continual 
measurement of FRC in mechanically ventilated subjects. The new method measures 
FRC using the “CO2 wash-in” signals during the onset of a partial CO2 rebreathing 
maneuver that is automatically initiated every three min by a CO2 rebreathing 
noninvasive cardiac output monitor (NICO2, Respironics, Wallingford, Connecticut). In 
an oleic acid model of ARDS/ ALI in mechanically ventilated animals, we measured the 
FRC before, during, and after lung injury, with two methods: CO2 wash-in and nitrogen 
wash-out. The aims of the study were to evaluate the new method in a mechanical lung 
model and to compare FRC measurements with the two methods in mechanically 
ventilated animals during induced lung injury. We demonstrate that the CO2-based FRC 




3.3.1 Nitrogen Wash-Out Method 
We used a variation of the nitrogen wash-out FRCmeasurement method published 
by Olegard et al[16] as the reference measurement. This method has been described in the 




method required a brief (< 5 min) 02 step increase in FIO2 (eg, from 0.4 to 0.6). The 
volume of released nitrogen and the change in nitrogen concentration following the 
change in FIO2 were used to calculate FRC.  
Oxygen was analyzed with a sidestream paramagnetic O2 analyzer (Datex, 
Helsinki, Finland). CO2 was measured with an infrared analyzer, and flow was measured 
with a differential pressure-type pneumotachometer, both of which are integrated in the 
NICO2 mainstream sensor (model 7300, Respironics-Novametrix, Wallingford, 
Connecticut). The gas analyzers were calibrated with calibration gas prior to the 
experiment. Each of the analyzers automatically re-zeros periodically to avoid baseline 
drift. Gas for the sidestream analyzer was sampled at the ventilator circuit Y-piece, and 
the mainstream sensor was placed between the gas sampling adaptor and the endotracheal 
tube. Both inspired and expired gases were measured continuously.  
The raw data of flow and gas concentration measurements were sampled at 100 
Hz and processed digitally using custom-written software to generate end-tidal and 
volumetric O2 and CO2 measurements and tidal volume (VT). We calculated oxygen 
consumption from the directly measured CO2 consumption (VCO2 ) and the minimum/ 
maximum difference in the O2 signal. We assumed that since the waveform of the fast 
oxygen signal is an inverted, scaled version of the capnogram, oxygen consumption can 
be calculated asVCO2 multiplied by the minimum/ maximum difference in the O2 divided 
by the minimum/ maximum difference in CO2.[9,16] We calculated end-tidal and mixed 
nitrogen fraction (FN2 ) as the balance gas (FN2 - 1 - FO2 - FCO2 ). Nitrogen excretion was 
calculated as the difference between expired volume multiplied by mixed expired N2 




baseline data had been collected, the nitrogen wash-out FRC measurement was initiated 
by increasing the FIO2 by 0.2 for each measurement, within the range of 0.3 to 1.0. 
Typically, the successive step changes in FIO2 for three measurements were 0.4 to 0.6, 0.6 
to 0.8, and 0.8 to 1.0. The volume of excreted N2 (VN2 ) was recorded during wash-out. 
The wash-out at each step change of FIO2 was allowed to continue to completion before 
the next measurement was begun.  
The series of measurements was completed within about 10 min, with the hope 
that absorption atelectasis caused by the higher FIO2 would be minimized. Typical time to 
atelectasis with FIO2 of 0.4 is 120 min, with FIO2 of 0.8 is 60 min, and with FIO2 of 1.0 is 50 
min.[17]  
FRC was calculated as the ratio of the volume of nitrogen excreted over a series 
of breaths divided by the change in end-tidal nitrogen fraction observed during the same 
series of breaths:  
 
VN2/(FetN2end – FetN2ini) [3.1] 
 
where VN2 is the volume of nitrogen leaving the lungs during the test, FetN2ini is the initial 
fraction of end-tidal nitrogen prior to the increase in FIO2 , and FetN2end is the fraction of 
end-tidal nitrogen at the end of the test. It should be noted that this calculation ignores the 
excretion of N2 from the tissues. The effect of N2 excretion from the tissues on the FRC 
measurement should be small (< 100 mL) and consistent across the animals used in our 
study.[18] Because the published studies that describe the methods for estimating the 
volume of N2 excretion in response to increased FIO2 assume human rather than porcine 




The repeatability of the FRC measurements made during the successive FIO2 
increases was assessed by recording and comparing individual measurements. The 
average measured FRC with the nitrogen wash-out method was used as the reference 
value for comparison with the CO2- based measurements.  
 
3.3.2 CO2 Wash-In Method 
FRC measurements with the CO2 wash-in method were made with an on-airway 
infrared CO2 analyzer, while airway flow was measured with an integrated differential 
pressure-type pneumotachometer, both of which are integrated in the NICO2 partial 
rebreathing cardiac output monitor. The monitor automatically actuates a pneumatic 
valve to commence partial CO2 rebreathing once every 3 min. The rebreathing period 
lasts 35 seconds and is used to measure pulmonary capillary blood flow. To calculate the 
FRC with the CO2 wash-in method, only the first breath of the rebreathing period is 
needed, wherein the changes in end-tidal and volumetric CO2 are recorded. Figure 3.1 
depicts the typical CO2 rebreathing signals.  
The calculations are as follows:  
 
FRC x FCO2(n) = FRC x FCO2(n–1) + VbCO2 - VeCO2  [3.2] 
FRC x [FCO2(n) - FCO2(n-1)] = VbCO2 - VeCO2  [3.3] 
 
where FCO2(n) is the fraction of end-tidal CO2 in the current breath (n), FCO2(n-1) is the 
fraction of end-tidal CO2 in the previous breath (n-1), VbCO2 is the volume per breath of 
CO2 passing from the blood into the FRC, and VeCO2 is the volume per breath of CO2 




































Figure 3.1. Example rebreathing signals. Changes in end-tidal CO2 (PetCO2) (above) and 






It is assumed that the CO2 excretion rate during the baseline period before 
rebreathing VCO2baseline is at a steady state and that the amount of CO2 eliminated per 
breath at the mouth is equal to the volume eliminated from the blood in the alveoli. 
 
FRC = (VCO2baseline - VeCO2(n))/(FCO2(n) - FCO2(n–1))  [3.4] 
 
The numerator of equation 4 reflects the amount of CO2 in excess of the amount 
delivered by the blood and retained in the FRC due to rebreathing. This equation is 
simply a one-breath wash-in method using a soluble gas. Only the first breath is used 
because the increase (or decrease) in intra-alveolar CO2 quickly changes the rate of CO2 
delivery to the alveoli. Evaluating only a single breath minimizes that error.  
The actual volume measured by this method includes not only the FRC but also 
the effective volume of the other stores of CO2 in the lung, including the lung tissue and 
the blood. To compensate for these extra CO2-storing sites, the FRC is calculated as: 
 
FRC = 0.45 x (VCO2baseline - VeCO2(n))/(FCO2(n) - FCO2(n-1))  [3.5] 
 
The factor of 0.45 was described by Gedeon et al[15] to account for the use of CO2 in 
place of an insoluble gas.  
A more precise calculation would include compensation for the effect of cardiac 
output and breath-to-breath changes in VT, but for the purposes of this study these 
assumptions provide reasonable estimates of FRC.  
It should also be noted that the last breath of rebreathing could also be used 
instead of the first breath, provided that the CO2 excretion rate had reached a steady state 




elimination from the blood to the FRC. This would be called the CO2 wash-out FRC, 
calculated as:  
 
FRC = 0.45 x (VCO2steady - VCO2(n))/ (FCO2(n-1) - (FCO2(n))  [3.6] 
 
where VCO2steady is the volume of CO2 excreted in the last breath of rebreathing in the 
steady state, VCO2(n) is the CO2 excreted in the first breath following rebreathing, FetCO2(n-
1) is the fraction of end-tidal CO2 in the first breath following rebreathing, and FetCO2(n) is 
the fraction of end-tidal CO2 in the last breath of rebreathing. This method assumes that a 
steady state condition was achieved during rebreathing. 
 
3.3.3 Bench Validation of the CO2 Wash-In Method With a Lung Model 
A training/test lung (Michigan Instruments, Grand Rapids, Michigan) was driven 
by a ventilator (900c, Siemens-Elema, Solna, Sweden) and infused with 250 mL/min 
CO2. A fan inside the lung completely mixed the gases. VCO2 and end-tidalCO2 
measurements were obtained from the NICO2 monitor. Partial rebreathing was 
automatically induced by the monitor for 35 seconds every 3 min. PEEP was changed 
from 0 cmH2O (FRC = 1.47 L) to 20 cmH2O in steps of 5 cmH2O, to increase the FRC to 
a maximum of 2.75 L. At each PEEP level, 2 CO2-wash-in-based FRC measurements 
were recorded, and the known volume of the mechanical lung was also recorded. At the 
end of the experiment, the PEEP was reduced back to zero, and the measurements were 
again recorded. The averageCO2 wash-in measurements at each PEEP step were 







3.3.4 Bench Validation of the Nitrogen Wash- 
Out Method with a Lung Model 
The training/test lung was set up as described for the CO2 validation. O2 was 
measured using a paramagnetic fast oxygen sensor (Capnomac, Datex, Helsinki, 
Finland). Step changes in N2 were imposed in the simulator by increasing FIO2 from 0.7 to 
0.9. PEEP was applied at four different levels, from 0 cm H2O to 20 cm H2O. The PEEP 
was returned back to zero for the final measurement set. At each PEEP step, the known 
value of FRC was recorded and two nitrogen wash-out-based FRC measurements were 
recorded. The average measurements at each PEEP step were compared with linear 
regression and Bland-Altman statistics to the known volumes. 
 
3.3.5 Animal Testing Protocol 
Using an approved animal research protocol, six healthy pigs, of mixed gender 
(38.8 -50.8 kg), were fasted, with free access to water overnight before they were given 
an intramuscular bolus of Telazol (4 mg/kg). Following tracheal intubation, the animals 
were ventilated with a mechanical ventilator (Esprit, Respironics, Carlsbad, California) 
with a VT of 10 mL/kg, FIO2 of 0.4, and an inspiratory-expiratory time ratio of 1:2. The 
respiratory rate was adjusted to maintain the nonrebreathing end-tidal PCO2 near 35 mm 
Hg. An 18-gauge arterial cannula was inserted into the femoral artery to continuously 
measure blood pressure and to facilitate arterial blood gas samples. General anesthesia 
was maintained via continuous infusion of propofol (100 -300 ug/kg/min), with a target 
mean blood pressure of 100 mm Hg. The animals were paralyzed with a continuous 
infusion of pancuronium (1 mg/kg/h). A flow-directed pulmonary artery catheter was 




assessed by hemodynamic waveforms. Mixed venous blood gas samples were drawn 
from the catheter tip. Venous admixture (shunt fraction) was calculated with the 
measured arterial and venous blood gas data. Lactated ringers solution was given 
intravenously at 6 mL/ kg/h throughout the experiment. The NICO2 monitor was placed 
in the breathing circuit between the endotracheal tube and the Y-piece. The partial CO2 
rebreathing signals obtained from that monitor were used to calculate FRC.  
The protocol was divided into two phases: a healthy lung phase, and an oleic acid 
lung injury phase that simulated ARDS/ALI. In the healthy lung phase the PEEP was set 
to 0, 5, 10, and 15 cm H2O. At each PEEP level we compared the average of 3 FRC 
measurements from CO2 wash-in to the average of three nitrogen wash-out 
measurements. To ensure that the effects of each PEEP adjustment had stabilized, no 
FRC measurements were made in the first 20 min after each PEEP change. Then, partial 
rebreathing data (end-tidal CO2 and CO2 excretion in response to partial rebreathing) 
were collected for 12 min (four rebreathing cycles, 3 min each) with the NICO2 monitor. 
Next, three reference nitrogen wash-out measurements were recorded. After collecting 
the nitrogen wash-out data, the PEEP was increased to the next level and the next 
measurement sequence was repeated. Arterial blood gas measurements were collected 
between the CO2 wash-in and nitrogen wash-out measurements at each PEEP level. 
Average cardiac output (measured via bolus thermodilution), heart rate, arterial blood 
pressure, pulmonary artery blood pressure, and oxygen saturation, were also noted at 
each PEEP level.  
Following FRC measurement at each of the 4 PEEP levels in healthy lungs, lung 




the proximal port of the pulmonary artery catheter. A syringe pump was used to deliver 
the acid continuously over a 15-min period. We allowed 1 hour for the injury to develop 
before resuming comparison FRC data collection. Injury was confirmed by decreased 
static lung compliance and lung auscultation. After the lung injury had been created, we 
repeated the data collection procedure at each PEEP level: 0, 5, 10, and 15 cm H2O. The 
average FRC measurements made with each of the methods at each PEEP level were 




3.4.1 Bench Validation Results: Comparison with the Known Lung Volume 
In the bench validation, the average error in the FRC measured by the CO2 wash-
in system was 37 mL with limits of agreement (LOA) ± 201 mL, which was equivalent to 
1.7% of the true FRC. The squared correlation was r2= 0.96 (Figure 3.2).  
The average error in the FRC measured by the CO2 washout system was 508 mL 
with limits of agreement (LOA) ± 370 mL, which was equivalent to 27% of the true FRC. 
The correlation coefficient was r2= 0.95. We observed that, because of the limitations of 
the physical lung model, the requirement of the CO2 wash-out method that steady state 
end-tidal CO2 be attained during rebreathing was not met. 
The average error with N2 wash-out was 6 mL with LOA ± 83 mL, which was -
0.02% of the true FRC. The squared correlation was r2 = 0.99 (see Figure 3.2). 
 
3.4.2 Bench Validation CO2 Measurement Repeatability 
The average error in the FRC measured by the CO2 wash-in system with duplicate 




Figure 3.2. Regression analyses with the simulated functional residual capacity 
(FRC) of the mechanical lung. FRC measurements from the CO2 wash-in method and the 





measurements was r2= 0.97. The average error in the FRC measured with the CO2 wash-
out system with duplicate measurements was -10 mL, with LOA of ± 109 mL. The 
squared correlation for duplicate CO2 wash-out measurements was r2= 0.99. 
 
3.4.3 Animal Testing Results 
In the healthy phase of the experiment, the median PaO2/FiO2 ratio was 443 
(range: 307-570) with an FiO2 of 0.3. Subsequent to the oleic acid injury, the median 
PaO2/FiO2 was 153 (range: 120-172). During the injury phase, the FiO2 was 0.4 in all 
animals except one, which had a PaO2/FiO2 of 169 with an FiO2 of 0.7. 
Figure 3.3 shows the individual CO2 wash-out FRC measurements from animal 3 
and depicts the change in FRC during evolution of the oleic acid induced ALI, as well as 
recovery of FRC volume following PEEP therapy. 
 
3.4.4 Comparison of CO2 Methods with Nitrogen  
Wash-out FRC Measurements 
When compared with nitrogen washout, the average error in the FRC measured 
by the CO2 wash-out system was -87 mL, with LOA of ± 263 mL (Figure 3.4). The 
correlation coefficient was r2= 0.89 (n = 50) and the slope was 1.018. For the ALI phase 
alone, r2 was 0.75, the slope was 1.13 and the bias was -77 mL, with LOA of ± 276 mL 
(n = 26).  
When CO2 wash-in data were compared with nitrogen wash-out, the average error 






Figure 3.3. Trend of CO2 wash-out functional residual capacity. Values were 
measured during evolution of and ventilator treatment for acute lung injury. PEEP = 





Figure 3.4. Bland-Altman comparison of CO2 wash-out and nitrogen-wash-out 





3.4.5 CO2 Wash-out and Wash-In FRC Measurement  
Technique Repeatability 
Regression of duplicate CO2 washout measurements at each PEEP resulted in an 
r2= 0.98 for all data combined and r2= 0.96 for just the ALI phase. The average error at 
each PEEP in the FRC for duplicate CO2 washout measurements was 2.9 mL with LOA 
of ± 124 mL for all data (n = 357) (Figure 3.5) and 3.8 mL ,with LOA of ± 95 mL for the 
ALI phase (n = 140). 
Regression of duplicate CO2 wash-in FRC measurements resulted in an r2= 0.93 
for all data combined and r2= 0.87 for just the ALI phase. The CO2 wash-in repeatability 
bias for all data together was 1 mL with LOA of ± 183 mL (n = 360). For the ALI phase 
only, the wash-in repeatability bias was 7 mL, with LOA of ± 161 mL (n = 147). 
3.4.6 Nitrogen Wash-Out Repeatability 
Regression of duplicate nitrogen wash-out measurements resulted in an r2= 0.98 
for all data combined and r2= 0.93 for just the ALI phase. The average error at each PEEP 
in the FRC from one nitrogen wash-out to the next was 13 mL, with LOA of ± 119 mL 
for all data together, and was 11 mL, with LOA of ± 111 mL for the ALI phase. 
 
3.5 Discussion 
We found good repeatability and clinically acceptable limits of agreement and 
bias between the proposed CO2 technique and the nitrogen wash-out method for FRC 
measurement. The CO2 technique allows automated, continual measurements of lung 
volume in mechanically ventilated subjects with ALI. An update in the measurement can 




Figure 3.5. Bland-Altman comparison of the first and second CO2 wash-out 
functional residual capacity (FRC) measurements. Measurements were taken during 





require a change in the ventilator settings and therefore could run independently and 
provide a trend of FRC measurements without clinician intervention. Since the method is 
repeatable, the clinician could also obtain early feedback from individual measurements 
regarding the physiologic response to changes made in PEEP and other ventilator 
settings. 
CO2 wash-out showed better LOA for both the comparison of accuracy and the 
comparison of repeatability than CO2 wash-in did in these subjects. This is probably 
because the signal-to-noise ratio of the first wash-out breath is slightly better, as long as 
steady state has been reached during the partial rebreathing period before the step change 
to nonrebreathing is actuated. Further testing is needed to determine whether CO2 wash-in 
or wash-out (or a combination of the two) is the best approach. The CO2 wash-in 
measurement makes use of the first breath of rebreathing, whereas the wash-out 
measurement is based on the last breath of rebreathing. The wash-out measurement 
requires the assumption that steady state has been reached during the rebreathing period. 
We observed no systematic difference between the CO2 wash-out and the nitrogen 
wash-out techniques. Each method responded similarly to the loss of aeration during the 
evolution of lung injury and to an increase in PEEP. This was expected, since both 
methods measure the communicating gas (i.e., the gas that flows into and out of the lung 
during tidal ventilation) rather than the whole enclosed gas volume. The nitrogen wash-
out method had a better signal-to-noise ratio than either CO2 method at larger FRCs. The 
repeatability of our implementation of the nitrogen wash-out was similar to what Olegard 
et al.[16] reported. They found a bias of -5 mL, with limits of agreement of 




Subsequent FRC measurements taken according to our protocol of successive, 
stepwise increases in FIO2 for a period of about 10 min did not show a decrease in FRC 
with each increase in FIO2. If we had observed a decrease with each subsequent 
measurement, we might have assumed that increasing the FIO2 had lead to absorption 
atelectasis. We observed no systematic difference between the first FRC measurement, 
which was taken at a lower FIO2, and the subsequent measurement, which was taken at a 
higher FIO2 . The average squared correlation between subsequent measurement pairs was 
r2 = 0.97, with an average difference of 12 mL. This implies that the method is insensitive 
to differences in FIO2 and that increases in FIO2 did not create a change in FRC due to 
absorption atelectasis or a similar effect. 
One limitation of FRC measurement with the CO2 method is the requirement that 
breath-to-breath VT be fairly consistent. Since changes in VT create variation in end-tidal 
CO2, and the CO2 method uses changes in end-tidal CO2 for the calculation, any 
respiratory pattern in which breath-to-breath volumes are inconsistent may be unsuitable 
for CO2 FRC measurements. Also, since the CO2 methods use a single breath for the 
calculation, lung volumes that are not well ventilated may not be represented in the 
measurement. 
Current practice involves monitoring of improvements in O2 saturation or 
dynamic compliance as a measure of a successful recruitment maneuver.[19–26] 
However, the improvement in O2 saturation following a recruitment maneuver is 
transient,[27] whereas the measurement of FRC remains a sensitive indicator of the 
aeration of the lung. Compliance change in early ALI/ARDS is a measure of aerated 




Rylander et al[1] found that FRC was a more sensitive indicator of decreased aeration and 
increased consolidation than is lung compliance, and he concluded that FRC might be a 
useful adjunct to PaO2 monitoring at the bedside.  
It has been shown[29] that when PEEP is added to lungs that exhibit repetitive 
alveolar collapse and expansion, the alveoli are stabilized and protected from ventilator-
induced lung injury. If continual monitoring of FRC could facilitate faster detection of 
the early phase of ARDS/ALI, which is characterized by deterioration in FRC due to 
collapse and flooding, rather than by fibrosis,1 perhaps ventilator treatment aimed at 
maintaining alveolar stabilization could be initiated sooner. Additionally, direct FRC 
measurements may aid in detection of de-recruitment in patients with ARDS/ALI caused 
by endotracheal tube suctioning.[30] 
It is imperative to use the minimum level of PEEP and volume therapies to recruit 
the lung, since barotrauma and volutrauma are risks associated with the treatments. If 
online FRC measurements were available, it would be possible to quickly confirm 
improvement in FRC following treatment with the most conservative approach possible. 
It has also been suggested that FRC could be a tool for the early detection of lung over-
inflation, by studying the predictive value of the ratio between PEEP-induced increase in 
FRC and PEEP-induced alveolar recruitment derived from the pressure-volume 
curves.[4] It remains to be seen whether earlier detection and treatment of ARDS/ALI 
will affect outcome. 
An alternative to the open-lung strategy has been termed “lung rest,” which is 
characterized by low airway pressure to prevent recruitment/derecruitment, small VT, and 




open-lung or the lung-rest strategy, the common intent is the prevention of repetitive 
alveolar collapse and expansion.[36] In either approach, continual monitoring of FRC 
would indicate an improvement or worsening of the FRC so that the clinician could be 
alerted that application of one of the strategies is required or has been successful. 
The ability of the lungs to exchange gas is driven by both ventilation and 
perfusion. Appropriate ventilator strategies must include the consideration that PEEP 
may significantly affect the amount and distribution of the pulmonary perfusion, even at 
modest pressure levels. It would be useful to be able to use the same rebreathing signals 
to assess both the ventilation and the perfusion of the lung. The partial CO2 rebreathing 
monitor avails several other cardiopulmonary measures from the same signals needed for 
FRC measurement, such as compliance, pulmonary capillary blood flow, pressure-
volume curves, and VCO2, each of which is an important factor in the analysis of gas 
exchange efficiency. For example, pulmonary capillary blood flow measurements could 
indicate a decrease in perfusion if excessive PEEP were used.  
The main drawback of the CO2-based FRC measurement techniques is that CO2 is 
a soluble indicator gas that is carried in the blood. Changes in the alveolar concentration 
affect the volume of CO2 delivered to the alveoli, which makes the assumption of 
delivery of CO2 to the alveoli by the blood less valid with each breath as rebreathing 
progresses. This limitation restricts analysis to the first or last breath of rebreathing. The 
use of a single breath for the measurement requires analysis of small changes in the 
signals, which may lead to measurement errors, especially when FRC is large. Another 
drawback of using CO2 as the indicator gas is that it is stored in the tissues of the lung and 




volume of the lung tissue and the blood. We apply the empirically derived multiplicative 
factor of 0.38 to reduce the effective lung volume to the gas volume that is the FRC. This 
factor is similar to that of 0.45 that Gedeon et al. [15] selected for their studies. This 
factor might be expected to be affected by increased tissue volumes, such as in 
edematous ARDS, but in this study the same factor was applied in both healthy and 
injured lungs, where the volume of fluid in the lung changed significantly. The 
application of a factor for pulmonary capillary blood flow or correction in VT from one 
breath to the next did not improve the repeatability or the comparison data in these 
studies, which is probably because the animals were mechanically ventilated and 
pulmonary capillary blood flow was not actively altered during the studies. 
Based of the limitation of CO2, it may be reasonable to use the CO2-based FRC 
measurement as a trend monitor rather than as an indicator of absolute gas volume in the 
lung. As with all tracer gas methods, the CO2 wash-in method measures only the part of 
the FRC that takes part in gas exchange, or the effective FRC. Methods such as computed 
tomography and body plethysmography also include the part of the FRC that is not 
communicating. Rylander et al [30] noted that the tendency to underestimate the FRC 
with a tracer gas was aggravated in ARDS because of the uneven distribution of 
ventilation. He estimated that the sulfur hexafluoride FRC method measured two thirds of 












In summary, convenient FRC measurement, combined with knowledge of cardiac 
output and other traditional measures, could be useful for guiding and monitoring the 
success of a recruitment maneuver, PEEP, and posture changes in treating lung injury. 
Such a monitor could simplify the maintenance of recruitment and oxygenation with 
minimal PEEP following a recruitment maneuver. Knowledge of FRC could aid in 
achieving alveolar stability, thereby protecting alveoli from shear stress and 
overdistention. If the method for measuring FRC were simple enough to use at the 
bedside, it might also be possible to detect de-recruitment sooner than by waiting to 
observe deleterious effects on PaO2 . 
A simpler FRC measurement method that would be more widely used in clinical 
medicine could help bring about broader clinical answers to questions such as the 
relationship between FRC and disease progression (eg, edema and fibrosis), the rate of 
recruitment after application of PEEP, the effect of fluid balance, and the relationship 
between gas exchange and FRC. We have shown that reproducible FRC measurements 
can be made with CO2. This method requires no interruption or changes to mechanical 
ventilation and could be used continually to monitor FRC in ARDS/ALI patients. 
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There is a need for a bedside functional residual capacity (FRC) measurement 
method that performs well in intensive care patients during many modes of ventilation 
including controlled, assisted, spontaneous and mixed. We developed a modified multiple 
breath nitrogen washout method for FRC measurement that relies on end-tidal gas 
fractions and alveolar tidal volume measurements as inputs but does not require the 
traditional measurements of volume of nitrogen or oxygen. Using end-tidal 
measurements, not volume, reduces errors from signal synchronization. This study was 
designed to assess the accuracy, precision and repeatability of the proposed FRC system 
in subjects with variable ventilation patterns including some spontaneous effort. 
 
4.1.2 Methods 
The accuracy and precision of measurements were assessed by comparing the 
novel N2 washout FRC values to the gold standard, body plethysmography, in twenty 




measurements in twenty intensive care patients whose lungs were under controlled and 
assisted mechanical ventilation. 
 
4.1.3 Results 
Compared to body plethysmography, the accuracy (mean bias) of the novel 
method was -0.004 L and precision (1 standard deviation) was 0.209 L (-0.1 ± 5.9% of 
body plethysmography). The difference between repeated measurements was 0.009 ± 
0.15 L (mean ± standard deviation) (0.4 ± 6.4 %). The coefficient of repeatability was 
0.31 L (12.7%). 
 
4.1.4 Conclusions 
The modified multiple breath nitrogen washout method for FRC measurement 
provides improved precision and equivalent accuracy and repeatability compared to 
existing methods during ventilation with variable ventilation patterns. Further study of 
the novel N2 washout method is needed. 
 
4.2 Introduction 
Measurements of functional residual capacity (FRC) have great potential for 
improving care for patients undergoing mechanical ventilation, for example, by guiding 
ventilation management to improve gas exchange in patients with acute lung injury and 
acute respiratory distress syndrome[1-2]. Traditional methods of FRC measurement[3-6] 
have been valuable for researching disease progression and monitoring ambulatory 
patients but are often impractical at the bedside because they are bulky, expensive, 
sensitive to leaks, and require uncommon tracer gases. Recent research has addressed the 




wash-in/ washout and multiple breath nitrogen washout[7-14]. The volume-based systems 
depend on accuracy of the volume measurement (flow x concentration). While the 
volume-based methods have proven to be clinically acceptable (1 SD of the error = 8.5%) 
with unconscious subjects under controlled mechanical ventilation (CMV) [13], their 
precision during the more irregular respiratory rate and tidal volume of spontaneous 
ventilation, which can lead to large errors in volume measurement, has yet to be 
demonstrated (1 SD of the error = 13.1-15.8%)[8 10 15]. 
Fewer than half of intensive care patients’ lungs are mechanically ventilated with 
CMV[16]. Thus, there is a need for a bedside FRC measurement method that is accurate, 
precise and repeatable in all modes of ventilation, when controlled, assisted, spontaneous 
and mixed. We have developed a FRC measurement system that is not volume-based and 
requires fewer than 2 min to set up. The inputs for our FRC measurement system include 
end-tidal gas fraction and alveolar tidal volume, but do not include traditional 
measurements of volume of oxygen (VO2) or nitrogen (VN2).  
To assess the clinical performance of our new system, we designed a feasibility 
study in subjects with variable ventilation patterns including some spontaneous effort. 
The goals of this study were: 1) to evaluate the accuracy and precision of the modified 
multiple breath nitrogen washout FRC measurement system compared to body 
plethysmography, the clinical gold standard, in spontaneously breathing volunteers and 2) 
to assess the repeatability of duplicate FRC measurements in ICU patients whose lungs 






4.3.1 Device Description 
Figure 4.1 shows the device setup. Carbon dioxide was measured using an 
infrared analyzer and flow was measured using a differential pressure-type pneumotach, 
both of which are integrated in the NICO2 mainstream sensor (Model 7300, Philips-
Respironics, Wallingford, CT, USA). Oxygen was measured using a sidestream 
paramagnetic O2 analyzer (Capnomac, Datex, Helsinki, Finland). The response times 
(T10-90) of the carbon dioxide, flow and oxygen sensors were 60, 100 and 470 ms, 
respectively. Each of the analyzers automatically re-zeroed periodically to avoid baseline 
drift.  
Throughout the measurement period, raw data of flow and gas concentrations 
were sampled with a frequency of 100 Hz and processed digitally using custom-written, 
validated software to provide inspired and end-tidal O2 and CO2 measurements and tidal 
volumes. End-tidal nitrogen fraction (FETN2) was calculated as: FETN2 = 1 – FETO2 – 
FETCO2. 
4.3.1.1 FRC evaluation by modified multiple breath nitrogen washout.  During 
multiple breath nitrogen washout measurement, resident nitrogen in the lung is washed 
out subsequent to a step increase in FIO2. With each additional breath of alveolar 
ventilation at the increased level of FIO2 (and corresponding reduced FIN2), the nitrogen 
concentration in the lung is diluted. End-tidal nitrogen fraction is a measurement of 
nitrogen remaining in the lung (alveoli) for each breath throughout the washout. Figure 
4.2 illustrates the resulting decrease in the logarithm of end-tidal nitrogen fraction as a 




Figure 4.1: The device setup for the accuracy and precision study. The setup 
comprised a mouthpiece, sensors of flow, O2, and CO2, a blender to provide specific gas 






Figure 4.2: An example of the change in nitrogen modeled for one compartment 
during ventilation with varying tidal volumes. Expired nitrogen concentration is plotted 
on a logarithmic scale against cumulative alveolar tidal volume following a step increase 
in FIO2. Although the breaths are not all the same size, they fall on the same line 
following a change in FIO2 since the actual effective alveolar ventilation is measured on a 
breath-by-breath basis. Note that the slope of the line is related to functional residual 






related to the size of the FRC; a small FRC will result in a steeper slope compared to a 
large FRC. Note that data from both large and small breaths appear on the same line that 
relates gas concentration and cumulative alveolar ventilation. Rather than measurement 
of the volume of a gas that leaves the lungs, the technique relies on estimation of alveolar 
nitrogen concentration during washout and alveolar tidal ventilation of variable size. 
A healthy lung with normal and uniform distribution of ventilation behaves as one 
compartment and the resulting nitrogen washout curve is a single exponential. In a 
diseased or injured lung with nonuniform ventilation distribution, the resulting washout 
curve is slower and appears to contain more than one compartment, with each 
compartment washing out at a different rate.  
The lung compartments and corresponding nitrogen washout curves can be 
mathematically modeled with a multiple compartment system that describes the volume-
to-ventilation ratio of the lung compartments. For the work presented here, three lung 
compartments were modeled, but it is possible to choose fewer or more than three lung 
compartments. If the model is tuned correctly, the combination of the modeled lung 
compartment nitrogen washout curves will match the single nitrogen washout curve 
observed at the mouth (breath-by-breath FETN2) during the measurement (Figure 4.3). 
The sum of the three modeled lung compartment volumes is equal to the FRC.  
Each of the lung compartments was modeled separately as a first order difference 
equation based on mass conservation of nitrogen subsequent to a step change in inspired 
nitrogen and given ventilation. As such, it was assumed each lung compartment would 
have a predictable nitrogen concentration with each breath during the washout: 




Figure 4.3: The functional residual capacity was modeled as three lung 
compartments. The modeled change in the nitrogen fraction in the compartments during 






where FˆAN2C[n] was the modeled alveolar N2 fraction in the lung compartment for the 
present breath, FˆAN2C[n-1] was the modeled alveolar N2 fraction in the lung compartment 










where VComp was the modeled lung compartment volume and VTC was the tidal 






3 was the number of modeled lung compartments, VTI was measured inspiratory tidal 
volume, VDaw was the airway deadspace and VDapp was the apparatus deadspace. VDaw 
and VDapp were measured for each breath throughout the study via volumetric 
capnography by the mainstream NICO2 sensor, which employs Fowler’s method of VDaw 
measurement. The mainstream volumetric capnometer enabled breath-by-breath 
measurement of effective alveolar ventilation, which was critical information for this 
method since it measured re-inspired VDaw and VDapp in addition to tidal volume. Neither 
of the deadspace volumes contributes to effective alveolar ventilation, and therefore they 
do not contribute to the change in alveolar nitrogen concentration during the washout 
period.  
The FˆAN2 of the three modeled lung compartments were averaged to produce a 


























where FˆETN2µ[n]  was the modeled end-tidal nitrogen fraction for each breath of the 
measurement period containing m breaths and three compartments and FAN2(0) was the 
initial nitrogen fraction in the lung, measured as baseline end-tidal nitrogen fraction 
before the washout period. The result of equation 4 corresponded to the breath-by-breath 
end-tidal nitrogen fraction signal recorded from the sensors during the FRC 
measurement. The same model applies during an increase in nitrogen concentration 
(wash-in).  
4.3.1.2 Determination of FRC by the multiple compartment model.  First, the 
FAN2(0) for each of the model compartments was set to the observed baseline FETN2 
value. In an iterative process, the computer algorithm then tested all possible 
combinations in 5 mL multiples over a wide range of physiologically possible lung 
compartment volumes (25-5000 mL) to identify the combination of lung compartment 
volumes required to minimize the squared difference between the simulated nitrogen 
curve of equation #4 and the FETN2 curve measured by the sensors. Once the 










It should be noted this calculation ignored the storage of N2 from the tissues. The effect 




4.3.1.3 Correction for shallow breaths.  For very shallow breaths that do not clear 
the airway deadspace, the end-tidal gas concentration is diluted by the inspired gas 
remaining in the airway, resulting in end-tidal gas measurements not reflective of the N2 
concentration in the alveoli. To address this sampling issue, the end-tidal nitrogen 
fraction was only recorded for breaths larger than twice the size of the measured airway 
deadspace. The alveolar ventilation recorded from a disregarded, small breath (VTC[i]) 
was added to the measured ventilation of the subsequent breath (VTC[i+1]) to maintain an 
accurate record of cumulative alveolar ventilation. 
4.3.2 Accuracy and Precision Testing 
4.3.2.1 Protocol.  Twenty healthy volunteers consented to an IRB-approved 
protocol that compared the FRC measurement obtained via modified multiple breath 
nitrogen washout to that of the body plethysmography method. Subjects were seated 
upright throughout the study period. For each subject, a set of nitrogen washout and body 
plethysmography FRC measurements were recorded in randomized order. The 
ambulatory volunteers qualified for study inclusion if they were between the ages of 18 
and 65. Exclusion criteria included known cardiac or pulmonary disease, including but 
not limited to asthma, COPD, history of smoking, and existing upper respiratory tract 
infection. 
The subjects were instructed to wear a nose clip and breathe normally through a 
mouthpiece connected to the device. The gas analyzers were calibrated with calibration 
gas prior to the experiment. A ventilator operating in its engineering diagnostics mode 
(Esprit, Philips Medical, Carlsbad, CA) was used as a gas blender to create the specified 




the FIO2 was set to 0.3 and a period of 20 min was allowed for stabilization. Then, the 
nitrogen washout FRC measurement was initiated by switching the inspired oxygen 
fraction to 0.5. After a period of five min was allowed for nitrogen washout, the inspired 
oxygen fraction was increased to 1.0. Again, the washout was continued for five min. The 
inspired oxygen fraction was again set to 0.3 for 20 min and the two step increases in 
oxygen were each repeated once. The average FRC from the four measurements was 
recorded. Upon analysis of the data, washout to a stable plateau value was confirmed for 
all measurements as defined by standard deviation of FETN2 from five successive breaths 
of less than 0.05. 
4.3.2.2 FRC evaluation by body plethysmography method. Body plethysmography 
FRC measurement was conducted by trained staff in the Pulmonary Laboratory at the 
University of Utah Health Sciences Center in accordance with the manufacturer’s 
specifications using the Collins body plethysmograph (Model BP, Warren E. Collins Inc., 
Braintree, MA) and standard plethysmography equations[18]. Three measurements of FRC 
within 5% of each other were obtained[19- 20]. The mean of the individual measurements 
was recorded as the reference FRC for each volunteer. 
  4.3.2.3 Statistical analysis.  Data are presented as mean values ± standard 
deviation (SD) if not otherwise stated. The modified nitrogen washout FRC 
measurements were assessed for agreement with body plethysmography FRC by means 
of Bland-Altman statistics, which yielded the mean difference (bias) and precision (1 SD 
of the difference) in addition to the upper and lower 95% limits of agreement (bias ± 





4.3.3 Repeatability Testing  
4.3.3.1 Device description.  Figure 4.4 shows the device setup. Carbon dioxide 
and flow were measured in the same way as in the accuracy testing. The one-way tubing 
and gas blender of the accuracy testing setup were replaced by the patient’s breathing 
circuit and ventilator (Puritan Bennett 840, Covidien-Nellcor and Puritan-Bennett, 
Carlsbad, CA, USA). The sidestream oxygen sensor was replaced with a mainstream 
photoluminescence analyzer (modified NICO2, Philips-Respironics, Wallingford, CT, 
USA). The response time (T10-90) of the mainstream oxygen sensor to a step change of O2 
concentration was 220 ms.  
4.3.3.2 Protocol.  In compliance with the IRB-approved study protocol, 20 ICU 
patients (12 women and 8 men) whose lungs were intubated and mechanically ventilated 
were enrolled in the FRC measurement study after consent was obtained. Inclusion 
criteria included heart rate between 50 and 150 bpm, SpO2 greater than or equal to 90% 
and mean, systolic, and diastolic pressures between 65 and 150 mmHg, 90 and 180 
mmHg, and 50 and 110 mmHg, respectively. Exclusion criteria included severe 
respiratory failure, as indicated by pH less than 7.25; tidal volume less than 400 mL; 
respiratory rate greater than 35; hemodynamic instability, defined as a mean arterial 
pressure of less than 65 mmHg despite treatment with pressors; positive end-expiratory 
pressure (PEEP) greater than 5 cm H2O; and severe COPD, defined as FEV1 less than 
50% of the predicted value. Patients with potential for elevated ICP, chest tubes or recent 
history of hemopneumothorax, blunt chest trauma, or documented low cardiac output 




Figure 4.4: The device setup for the repeatability study. The setup comprised 





Five of the enrolled patients were treated with pressure control ventilation, and 
the other 15 were treated with pressure support ventilation. The gas analyzers were 
calibrated with calibration gas prior to the experiment. A respiratory therapist temporarily 
disconnected the circuit to place the device between the endotracheal tube and the Y-
connector of the ventilator tubing. The ventilation was allowed to stabilize for one hour 
after sensor placement before FRC measurements were taken.  
FRC measurements were taken by increasing the FIO2 from the clinically 
determined, set baseline to 1.0 for 5 min and then returning the FIO2 setting to the set 
baseline level for 5 min. The average FRC from the two resulting nitrogen curves was 
taken as one measurement. First, two nitrogen washout measurements were completed. 
After approximately 30 min, two more nitrogen washout measurements were completed. 
Upon analysis of the data, washout to a stable plateau value was confirmed for all 
measurements as defined by standard deviation of FETN2 from five successive breaths of 
less than 0.05.  
Raw data of flow and gas concentrations from each breath were processed 
digitally as described above to calculate cumulative alveolar ventilation and nitrogen 
concentration. Modified multiple breath nitrogen washout FRC measurement was 
calculated with the same multiple compartment method used for the accuracy testing. 
4.3.3.3 Statistical analysis.  Data are presented as mean values ± SD if not 
otherwise stated. The repeatability of the measurements was evaluated by comparing 
each measurement to the subsequent one taken in the same patient. The mean and 
standard deviation of the differences and the coefficient of repeatability (2 x SD of the 




using linear regression and Bland-Altman analyses. A probability value of <0.05 was 
considered as significant.  
4.4 Results 
4.4.1 Accuracy and Precision 
Eleven males and nine females participated in the study. Mean age of the subjects 
was 31 ± 11.5 years. Mean height was 174 ± 10.6 cm. Mean weight was 71 ± 12.1 kg.  
FRC measured by body plethysmography was 3.55 ± 0.87 L with range 2.3 L to 5.6 L.   
Figure 4.5 shows the Bland-Altman analysis of agreement between the modified 
multiple breath nitrogen washout and body plethysmography FRC. The bias (N2-body 
plethysmography) was -0.004 with precision (1 SD of the error) of 0.209 L (-0.1 ± 5.9% 
of body plethysmography) and 95% limits of agreement of -0.41 to 0.41 L (-11.7 to 11.5 
% of body plethysmography).   
4.4.2 Repeatability 
Mean measured nitrogen washout FRC was 2.4 ± 0.7 L (range 1.18 to 3.63 L). 
Mean age was 57 ± 17. Mean weight was 87 ± 28 kg. Mean set baseline FIO2 was 0.41 ± 
0.09. 
Figure 4.6 shows the mean difference between repeated measurements was 0.009 
± 0.15 L (0.4 ± 6.4 %) and the 95% limits of agreement were between -0.29 and 0.31 L (-
12.1 to 12.8%). The coefficient of repeatability was 0.31 L (12.7%). Subsequent 
measurements were not statistically different (p = 0.73). Linear regression analysis 
between the first and second measurements yielded R2 of 0.96 (n= 39), y = 0.99x +0.01 





Figure 4.5: Bland-Altman plot comparing agreement between functional residual 
capacity by modified multiple breath nitrogen washout and body plethysmography. The 





Figure 4.6: Bland-Altman plot comparing differences between the repeated 
modified multiple breath nitrogen washout functional residual capacity measurements. 






Figure 4.7: Linear regression analysis of the first and second modified multiple 







This study of a novel multiple breath nitrogen washout method for functional 
residual capacity measurement demonstrated accuracy of -0.004 L (-0.1% of body 
plethysmography), precision of 0.209 L (5.9%) and repeatability of 6.4%. The precision 
we observed was better and the accuracy and repeatability were equivalent to existing 
methods during ventilation with variable breath patterns including some spontaneous 
effort. Our method is more precise because it used FETN2 rather than volume of expired 
nitrogen or oxygen as an input. Improved measurement precision can better inform 
titration of therapeutic changes to mechanical ventilator settings to restore normal FRC 
and increase gas exchange for patients treated with many modes of mechanical 
ventilation, including controlled, assisted, mixed and spontaneous. 
The accuracy and precision (-0.1 ± 5.9%) (mean ± SD of the error) of our FETN2–
based washout system compared favorably with an expired O2 volume-based (VO2) 
washout system evaluated in two studies (2.6 ± 13.1%) and (-11.7 ± 15.8%) in 
spontaneously breathing patients[8 10]. GE Healthcare currently offers the only 
commercially available system for O2 volume-based FRC measurement in patients with 
mechanically ventilated lungs, but it has not been evaluated in spontaneously breathing 
patients. Published accuracy data for the GE system only provide results for an evaluation 
using a passive lung model with controlled mechanical ventilation; accuracy was between 
1-3% and precision was between 4-6% of the reference volume, depending on the FIO2 
step change used[7]. 
The repeatability of our system (SD of the error = 6.4%) for ICU patients treated 




of within 10% and was comparable to results (SD of the error = 6.5%) obtained using a 
mass spectrometer[14] and a system evaluation with 250 measurements in 36 patients (SD 
of the error = 6.5%)[13]. Olegard and coworkers[7] reported 1 SD of the error of 0.178 L 
during CMV, which is slightly higher than the 0.15 L (6.4%) SD of the error we observed 
with our system. The data analyzed in our study included patient-triggered ventilation via 
pressure support mode, which typically results in highly variable tidal volumes and 
breath rates that increase the error in integration of flow and concentration waveforms for 
volume-based methods. For our group of 20 patients, the average tidal volume was 491 ± 
88 mL (5.6 ± 1 mL kg-1) and the average respiratory rate was 26 ± 7.0 br min-1; the 
coefficient of variation in tidal volume was 0.21 ± 0.07 and in respiratory rate was 0.16 ± 
0.08. The good repeatability we observed even during highly variable ventilation patterns 
indicates it should be possible to quickly detect changes in and adjust FRC during 
patient-triggered, assisted mechanical ventilation.  
The modified multiple breath nitrogen washout method described here is 
analogous to work published by Hashimoto and colleagues, who used an electrical analog 
model of the lung to describe gas distribution in six compartments[21]. By manually 
altering potentiometers, he adjusted the modeled FETN2 until it matched the recorded 
FETN2 signal and then found FRC from the experimentally determined parameters. The 
process was limited to offline analysis of 6-18 breaths of uniform volume and an assumed 
airway dead space volume. In contrast, the method tested here accounted for the tidal 
volume, apparatus dead space, and airway dead space measured for each breath. The 
method searched out the optimal lung compartment volumes needed to estimate the 




center on the change in nitrogen concentration within the lung (alveoli) in response to a 
step change in inspired oxygen rather than on the precise volume of nitrogen or oxygen 
leaving or entering the lungs.  
The novel FRC measurement is based on end-tidal gas measurements and 
therefore does not rely on calculating a change in VN2 or VO2 as other methods do, for 
example by estimation of VO2 from measured VCO2 and an assumed respiratory quotient 
(RQ). The change in gas viscosity during the washout maneuver is not an applicable issue 
since measurements of VO2 are not required. In contrast to volume-based methods, it is 
possible to use end-tidal measurements that are not perfectly synchronous, which leads to 
higher precision and repeatability of FRC measurements during variable ventilation 
patterns. The use of end-tidal gas measurements and a mainstream gas analyzer 
eliminated the need for corrections required by other systems due to sampling delay, 
response, or synchronization errors[22]. Further noise reduction was achieved by 
eliminating the end-tidal gas measurements of the very shallow breaths. It may also be 
true that FRC itself is somewhat variable during spontaneous and assisted ventilation[14], 
which is an unavoidable error for any system.  
Like Olegard’s system[7], this method assumes: 1) cellular metabolism and gas 
exchange between lung capillary blood and alveoli are stable and 2) the non-homogeneity 
in alveolar gas distribution is constant throughout the measurement period. Both 
assumptions are necessary for end-tidal gas measurement use. Unlike the Olegard system, 
an assumed RQ is not required by our method to allow FIO2 to increase up to 1.0. 
Assumptions made by other systems related to fixed RQ, ventilation volumes, and 




hold true for a required 5-10 min measurement period during spontaneously triggered, 
assisted ventilation and the associated variable breath patterns[7 13 23-25].  
One advantage of the method evaluated here is that VTalv did not need to be 
estimated from average values of VCO2, which varies with tidal volume size and 
contributes to error. Instead, VTalv was directly measured by the mainstream, integrated 
CO2 and flow sensor of the NICO2 monitor and was calculated breath-by-breath by 
subtracting the Fowler’s airway dead space and apparatus dead space from the directly 
measured tidal volume. The main drawback of using mainstream volumetric capnography 
is the possibility for patient secretions to accumulate on the sensor window or within the 
differential pressure tubing. To ameliorate these issues, the sensor is heated to maintain a 
dry sensor window, and the differential pressure tubing is periodically purged with a 
volume of air to clear any secretions. We did not observe any problems with the 
mainstream sensor during data collection.   
The FETN2-based system presented here does not require specific mechanical 
ventilator settings, a particular ventilator brand, patient cooperation or manual 
intervention to measure FRC. A FETN2-based washout monitor could be both independent 
from and compatible with any ventilator that can make step changes in FIO2 since the 
only parameters required for the FRC measurement are end-tidal oxygen and carbon 
dioxide fractions and alveolar tidal volume. A limitation of our implementation, however, 
is that the change in FIO2 was adjusted manually. The system is currently designed to 
recognize a manual step change in FIO2 and automatically start the FRC analysis. For 





One concern related to ventilation with high FIO2 is the possibility of absorption 
atelectasis. In the repeatability testing protocol, the FIO2 was always turned from baseline 
up to 1.0, regardless of the starting point for FIO2, in order to simplify protocol execution. 
We assumed 5 min was not enough time for atelectasis to form, as absorption atelectasis 
has been shown to develop after approximately 45 min at FIO2 of 1.0[26]. However, with 
an automated system, it could be possible to standardize a smaller step size and limit 
exposure to extremely high FIO2.  
It would be valuable in future testing to analyze the accuracy with smaller step 
changes in FIO2, especially for patients who require high baseline FIO2 for arterial 
oxygenation. The accuracy and precision study was performed with FIO2 steps sizes of 
0.2 and 0.5, and both step sizes provided accurate FRC measurements. It is likely the 
mean step size of 0.6 we used in the repeatability testing is larger than necessary for 
reliable measurement. Based on analysis by other groups[7 13], we expect a smaller FIO2 
step change could be used without significant loss in accuracy.  
Limitations of this study include the limited degree of lung disease in the patient 
set and lack of a gold standard for FRC measurement in patients with mechanically 
ventilated lungs. Due to IRB restrictions, the ICU patients we studied were generally the 
healthiest among the patients in the ICU, and several of those tested were within two days 
of extubation. It would be interesting in future studies to monitor ICU patients throughout 
the evolution of disease and subsequent to treatment.  
An important subject for future research is to analyze the accuracy compared to a 
reference technique such as computed tomography in intensive care patients with 




how increased alveolar dead space and disturbed ventilation: perfusion (VQ) 
configuration affect the measurement. The FETN2-based method applies the same 
assumption of constant nonhomogeneity in alveolar gas distribution throughout the 
measurement period that other volume-based nitrogen washout methods do. 
Theoretically, this method will be prone to less error due to use of end-tidal 
measurements in place of volume to estimate the change in nitrogen within the lungs if 
the assumption does not hold, but it would require a higher fidelity simulation or 
additional clinical research to investigate whether this is true. 
There remain few published studies of the utility of FRC measurement in 
critically ill patients, but recently there has been renewed interest in and reports of FRC 
measurement in clinical situations such as after suctioning [27-28], during weaning [23] and 
with application of positive end-expiratory pressure[29]. There is currently one 
commercially available system (FRC INviewTM, Engstrom Carestation, GE Healthcare, 
Chalfont St Giles, UK). As clinicians gain experience with reliable and precise FRC 
measurement during patient treatment, the role of FRC measurement will be more clearly 
defined. Further clinical studies should also evaluate the value of volume-to-ventilation 
distribution measurements made possible by a multiple compartment model such as the 
one presented here. 
In conclusion, we have shown that FRC assessment with the FETN2-based 
nitrogen washout technique provides improved precision and good accuracy in an 
evaluation with body plethysmography in spontaneously breathing volunteers. We have 
also demonstrated clinically acceptable repeatability in the ICU during controlled and 




highly variable ventilation patterns resulting from various degrees of spontaneous effort 
are commonplace. The measurement technique, which does not require measurement of 
volume of expired nitrogen or oxygen, demonstrated improved precision compared to 
volume-based systems recently evaluated in similar settings. The robust performance of 
the novel technique during ventilation with changing breath patterns suggests further 
study of the FETN2-based nitrogen washout FRC measurement technique is needed. 
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CLINICAL TESTING OF CARBON DIOXIDE SYSTEM 
 
5.1 Abstract 
5.1.1 Objective  
There is a need for an automated bedside functional residual capacity (FRC) 
measurement method that does not require a step change in inspired oxygen fraction. 
Such a method can be used for patients who require a high inspired oxygen fraction to 
maintain arterial oxygenation and for patients ventilated using a circle breathing system 
commonly found in operating rooms, which is not capable of step changes in oxygen. We 
developed a CO2 rebreathing method for FRC measurement that is based on the change in 
partial pressure of end-tidal carbon dioxide (PetCO2) and volume of CO2 eliminated 
(VCO2) at the end of a partial rebreathing period. This study was designed to assess the 
accuracy and precision of the proposed FRC measurement system compared to body 
plethysmography and nitrogen washout FRC. 
 
5.1.2 Methods 
Accuracy and precision of measurements were assessed by comparing the CO2 
rebreathing FRC values to the gold standard, body plethysmography FRC, in 20 
spontaneously breathing volunteers. The CO2 rebreathing FRC measurements were then 
compared to nitrogen washout FRC in 20 intensive care patients whose lungs were 
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mechanically ventilated. For each subject, an average value of CO2 rebreathing FRC was 
compared to the average gold standard method. Measurements were accepted for 
statistical analysis if they had been recorded from periods of stable tidal ventilation, 
defined as a coefficient of variation of tidal volume of less than 0.13. 
 
5.1.3 Results 
Compared to body plethysmography, the accuracy (average error) for the CO2 
rebreathing method during stable ventilation (n=8) was 0.03 L and precision (1 standard 
deviation of the error) was 0.29 L (0.8 ± 7.6% of body plethysmography). During stable 
mechanical ventilation (n=9), the accuracy was -0.02 L and precision was 0.26 L (-1.1% 
± 12.6% of nitrogen washout).  
 
5.1.4 Conclusions 
The CO2 rebreathing method for FRC measurement provides acceptable accuracy 
and precision during stable ventilation compared to the gold standards of body 
plethysmography and nitrogen washout. The results based on periods of stable ventilation 
best approximate the performance of the system in the likely areas of application during 
controlled mechanical ventilation. Further study of the CO2 rebreathing method is needed 
to evaluate accuracy in a larger group of controlled mechanical ventilation patients, 
including patients with respiratory insufficiency and significant lung injury. 
 
5.2 Introduction 
Measurement of functional residual capacity (FRC) in intubated and mechanically 
ventilated patients has been proposed to optimize positive end-expiratory pressure 
(PEEP), assess efficacy of recruitment maneuvers and prone positioning on lung 
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volumes, evaluate if endotracheal suctioning has adverse consequences, and identify 
alveolar derecruitment without changes in mechanical ventilator settings 1-5]. FRC 
measurements can provide information on the amount of recruited alveolar lung tissue 
involved in gas exchange and the level of stress and strain the lungs are subjected to[6-9]. 
Several reliable methods have been developed for FRC measurement. Body 
Plethysmography is a gold standard for ambulatory patients, but is not suitable for use 
during mechanical ventilation [10]. Sulfur hexafluoride (SF6) washout, while highly 
accurate, has been primarily limited to research settings since it is not approved for 
clinical use [11]. Nitrogen (N2) washout is accurate and can be used at the bedside during 
mechanical ventilation [12]. However, the N2 washout method requires a minimum 10% 
change in inspired oxygen within one breath, which is not possible with the widely used 
circle breathing systems during anesthesia. For intensive care patients receiving a high 
level of inspired oxygen fraction, it may be unacceptable to initiate a step change in 
inspired oxygen fraction for a FRC measurement.  
We describe here a method of FRC measurement for use in intensive care and 
operating room patients at any level of inspired oxygen fraction using a 35-second period 
of partial CO2 rebreathing. The single-breath transition from the steady state CO2 
rebreathing phase to the first breath of non-rebreathing is used to determine the FRC, 
which is calculated as the ratio of the change in excreted CO2 to the change in the end-
tidal CO2 over the single breath transition. 
Our goal is to test the accuracy of CO2 rebreathing FRC measurements compared 
to body plethysmography and N2 washout FRC in healthy volunteers and mechanically 





5.3.1 Device Description 
Figure 5.1 shows the device setup. Carbon dioxide was measured using an 
infrared analyzer and flow was measured using a differential pressure-type pneumotach, 
both of which are integrated in the NICO2 mainstream sensor (Model 7300, Philips-
Respironics, Wallingford, CT, USA). The integrated NICO2 sensor recorded parameters 
including end-tidal carbon dioxide (PetCO2), tidal volume (VT), excreted carbon dioxide 
(VCO2) and airway dead space (VDaw) for each breath. Oxygen was measured using a 
sidestream paramagnetic O2 analyzer (Capnomac, Datex, Helsinki, Finland). The 
response times (T10-90) of the carbon dioxide, flow and oxygen sensors were 60, 100 
and 470 ms, respectively. Each of the analyzers automatically re-zeroed periodically to 
avoid baseline drift. 
5.3.1.1 FRC evaluation by the CO2 rebreathing method. FRC measurements from 
the CO2 washout method were made using the NICO2 partial rebreathing cardiac output 
monitor. The monitor automatically actuates a pneumatic valve that is synched with the 
breaths to commence partial CO2 rebreathing (typically 40-60%) once every 3 min. The 
rebreathing period lasts 35 seconds and is used to measure pulmonary capillary blood 
flow (PCBF) and cardiac output [13,14]. To calculate the FRC using the CO2 washout 
method, only the first breath of the transition out of rebreathing is needed, wherein the 
changes in end-tidal and excreted CO2 are recorded. Figure 5.2 illustrates a typical CO2 
partial rebreathing measurement signal. 
The change in CO2 concentration within the FRC during the transition from one 




Figure 5.1: The device setup for the accuracy and precision study. The setup 
comprised a mouthpiece, sensors of flow and CO2, a rebreathing loop, a blender to 
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Figure 5.2: Example rebreathing signals. Changes in PetCO2 (above) and 









where VFRC* represents the functional residual capacity, FETCO2(i) is the fraction of end-
tidal CO2 in the current breath “i”, FETCO2(i+1) is the fraction of end-tidal CO2 in the next 
breath “i+1”, VPCBF is the pulmonary capillary blood flow measured by the NICO2 
rebreathing monitor, t is the time period of the analyzed breath, cCO2 is the content of 
CO2 of the pulmonary capillary blood flow, and VDCO2 and VECO2 are the rate of CO2 
excreted from the patient measured by the integrated NICO2 sensor during rebreathing 
and for the first breath after rebreathing has ended, respectively. 
As it is also assumed for the cardiac out and pulmonary capillary blood flow 
measurements of NICO2 cardiac output monitor, it is assumed that the CO2 excretion rate 
has reached a steady state during rebreathing such that the CO2 excretion rate is equal to 
the rate of CO2 elimination from the blood to the FRC. The equation describes a 1-breath 
wash-out method using a soluble gas. Only the first breath is used because the decrease in 
intra-alveolar CO2 quickly changes the rate of CO2 delivery to the alveoli. Evaluating 
only a single breath minimizes this error. 
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The change in cCO2 can be approximated as a change in the partial pressure of end-tidal 
CO2 (PETCO2) multiplied by the slope (S) of the CO2 dissociation curve (CO2 volume 
versus partial pressure curve)[15]. 
Although the equation above accounts for the CO2 stores in blood, the calculation 
for FRC overestimates the volume of FRC due to the effect of the CO2 stores in lung 
tissue. A factor of 0.55 can be applied to adjust for both the blood and lung tissue stores 
of CO2[16]. Since blood stores have already been accounted for, the factor (0.28) 
required to correct for the tissue stores alone is smaller: 
 
( ) .28.01 *FRCFRC VV ×−=  
 
5.3.2 Accuracy and Precision Compared to Body Plethysmography 
5.3.2.1 Protocol. Twenty healthy volunteers consented to an IRB-approved 
protocol that compared the FRC measurement obtained via CO2 rebreathing to that of the 
body plethysmography method. Subjects were seated upright throughout the study period. 
For each subject, a set of CO2 rebreathing and body plethysmography FRC measurements 
were recorded in randomized order. The ambulatory volunteers qualified for study 
inclusion if they were between the ages of 18 and 65. Exclusion criteria included known 
cardiac or pulmonary disease, including but not limited to asthma, COPD, history of 
smoking, and existing upper respiratory tract infection. 
The subjects were instructed to wear a nose clip and breathe normally through a 
mouthpiece connected to the device. The gas analyzers were calibrated with calibration 
gas prior to the experiment. A ventilator operating in its engineering diagnostics mode 




at a flow rate of 50 L min-1 and FIO2 set to 0.3. One-way valves were used to prevent 
rebreathing. A series of six rebreathing measurements was initiated by the NICO2 
monitor, which included 35 seconds of partial rebreathing every 3 min. Breath-by-breath 
measurements from the oxygen, carbon dioxide and flow sensors were recorded to a 
laptop computer.  
Since the FRC measurement is based on a transition recorded during a single 
breath and because FRC itself can be variable during ventilation with highly variable 
tidal volume, a requirement for accurate FRC analysis by this method is stable ventilation 
volume. A measurement recorded during stable ventilation was defined as one with a 
coefficient of variation of tidal volume from five successive breaths of less than 0.13. 
Upon analysis of the recorded data, individual measurements were categorized as 
containing either stable or unstable ventilation volume. Individual measurements 
containing unstable ventilation volume were eliminated from further analysis. The FRC 
for each subject was calculated as the average of the first four individual measurements 
containing stable ventilation volume. Subjects for whom four stable individual 
measurements were not obtained were not included in the statistical analysis. 
5.3.2.2 FRC evaluation by body plethysmography method. Body plethysmography 
FRC measurement was conducted by trained staff in the Pulmonary Laboratory at the 
University of Utah Health Sciences Center in accordance with the manufacturer’s 
specifications using the Collins body plethysmograph (Model BP, Warren E. Collins Inc., 
Braintree, MA) and standard plethysmography equations [17]. Three measurements of 
FRC within 5% of each other were obtained [18, 19]. The mean of the individual 




5.3.2.3 Statistical analysis. Data are presented as mean values ± standard 
deviation (SD) if not otherwise stated. The CO2 rebreathing FRC measurements were 
assessed for agreement with body plethysmography FRC by means of Bland-Altman 
statistics, which yielded the mean difference (bias) and precision (1 SD of the difference) 
in addition to the upper and lower 95% limits of agreement (bias ± 1.96*SD of the 
difference). The Bland-Altman statistics were calculated using a mean of four individual 
CO2 rebreathing FRC measurements for each subject. The within subject standard 
deviation of each measurement was verified to be constant and unrelated to the 
magnitude. Linear regression analysis was also performed. 
 
5.3.3 Accuracy during Mechanical Ventilation Compared to N2 Washout 
5.3.3.1 Device description. Carbon dioxide and flow were measured in the same 
way as in the body plethysmography accuracy testing. The one-way tubing and gas 
blender of the accuracy testing setup were replaced by the patient’s breathing circuit and 
ventilator (Puritan Bennett 840, Covidien-Nellcor and Puritan-Bennett, Carlsbad, CA, 
USA). A mainstream photoluminescence analyzer (modified NICO2, Philips-Respironics, 
Wallingford, CT, USA) was used to monitor end-tidal oxygen partial pressure. The 
response time (T10-90) of the mainstream oxygen sensor to a step change of O2 
concentration was 220 ms.  
Throughout the measurement period, raw data of flow and gas concentrations 
were sampled with a frequency of 100 Hz and processed digitally using custom-written, 
validated software to provide inspired and end-tidal O2 and CO2 measurements and tidal 





5.3.3.2 Protocol. In compliance with the IRB-approved study protocol, 20 ICU 
patients (12 women, 8 men) whose lungs were intubated and mechanically ventilated 
were enrolled in the FRC measurement study after consent was obtained from their 
authorized representative. Inclusion criteria included heart rate between 50 and 150 bpm, 
SpO2 greater than or equal to 90% and mean, systolic, and diastolic pressures between 65 
and 150 mmHg, 90 and 180 mmHg, and 50 and 110 mmHg, respectively. Exclusion 
criteria included severe respiratory failure, as indicated by pH less than 7.25; tidal 
volume less than 400 mL; respiratory rate greater than 35; hemodynamic instability, 
defined as a mean arterial pressure of less than 65 mmHg despite treatment with 
vasoactive medications; positive end-expiratory pressure (PEEP) greater than 5 cm H2O; 
and severe COPD, defined as FEV1 less than 50% of the predicted value. Patients with 
potential for elevated ICP, chest tubes or recent history of hemopneumothorax, blunt 
chest trauma, or documented low cardiac output states were also excluded. 
All enrolled patients were treated with mechanical ventilation (15 with pressure 
support mode and 5 with pressure control mode) according to the recommendations of 
the clinical team and the ventilator settings were not altered for the study. The subjects’ 
level of sedation was not altered in any way for the study, nor was neuromuscular 
blockade administered for ventilatory pattern management. The gas analyzers were 
calibrated with calibration gas prior to the experiment. A respiratory therapist temporarily 
disconnected the circuit to place the device between the endotracheal tube and the Y-
connector of the ventilator tubing. The ventilation was allowed to stabilize for one hour 
after sensor placement before FRC measurements were taken. A series of FRC 




method in randomized order. For the CO2 rebreathing method series of measurements, 
the activated NICO2 monitor initiated six automated measurements, which included 35 
seconds of partial rebreathing every 3 min. Breath-by-breath measurements from the 
oxygen, carbon dioxide and flow sensors were recorded to a laptop computer. 
A measurement recorded during stable ventilation was defined as one with a 
coefficient of variation of tidal volume from five successive breaths of less than 0.10. 
Upon analysis of the recorded data, individual measurements were categorized as 
containing either stable or unstable ventilation volume. Individual measurements 
containing unstable ventilation volume were eliminated from further analysis. The FRC 
for each subject was calculated as the average of the first four individual measurements 
containing stable ventilation volume. Subjects for whom four stable individual 
measurements were not obtained were not included in the statistical analysis.  
5.3.3.3 FRC evaluation by nitrogen washout. Reference FRC measurements were 
initiated by increasing the FIO2 from the clinically determined, set baseline to 1.0 for 5 
min and then returning the FIO2 setting to the set baseline level for 5 min. The average 
FRC from the two resulting nitrogen curves (1 wash-in and 1 washout) was taken as one 
measurement. Reference nitrogen washout FRC measurements were calculated according 
to the equations detailed elsewhere [20].  
First, two nitrogen washout measurements (2 X 1 wash-in and 1 washout) were 
completed. After approximately 30 min, two more nitrogen washout measurements were 
completed. Upon analysis of the data, washout to a stable plateau value was confirmed 
for all measurements as defined by standard deviation of FETN2 from five successive 




5.3.3.4 Statistical analysis. Data are presented as mean values ± SD if not 
otherwise stated. The CO2 rebreathing FRC measurements were assessed for agreement 
with modified nitrogen washout FRC by means of Bland-Altman statistics, which yielded 
the mean difference (bias) and precision (1 SD of the difference) in addition to the upper 
and lower 95% limits of agreement (bias ± 1.96*SD of the difference). The Bland-
Altman statistics were calculated using a mean of four individual CO2 rebreathing FRC 
measurements for each patient. The within subject standard deviation of each 
measurement was verified to be constant and unrelated to the magnitude. Linear 
regression analysis was also performed. 
 
5.4 Results 
5.4.1 Accuracy and Precision Compared with Body Plethysmography 
Twenty subjects were enrolled in the study. Technical difficulties in data 
collection resulted in two subjects not completing at least four CO2 rebreathing FRC 
measurements. Of the remaining 18 subjects who completed at least four measurements, 
eight subjects demonstrated ventilation with stable volume (four males and four females). 
Mean age of the eight subjects was 30.5 ± 11.3 years. Mean height was 175 ± 13 cm. 
Mean weight was 68.4 ± 14.5 kg.  FRC measured by body plethysmography was 3.9 ± 
1.1 L with range 2.3 L to 5.4 L.  
Figure 5.3 shows the Bland-Altman analysis of agreement between CO2 rebreathing 
and body plethysmography FRC for the eight subjects. The bias (CO2 - body 
plethysmography) was 0.03 L with precision (1 SD of the error) of 0.29 L (0.8 ± 7.6 % of 
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Figure 5.3: Bland-Altman plot comparing agreement between the functional 
residual capacity evaluated by CO2 rebreathing and body plethysmography. The dashed 





of body plethysmography).  Linear regression analysis of CO2 and body plethysmography 
FRC revealed R2 of 0.93 and slope of 0.88.   
 
5.4.2 Accuracy during Mechanical Ventilation 
Twenty subjects were enrolled in the study. Technical difficulties in data collection 
resulted in one subject not completing any CO2 rebreathing FRC measurements. Five 
patients did not complete at least four CO2 rebreathing FRC measurements due to 
interruptions caused by clinical events such as suctioning, physical therapy, bathing and 
treatment with nebulized medication. Of the remaining 14 subjects who completed at 
least four measurements, nine subjects demonstrated ventilation with stable volume (four 
males and five females). Mean measured nitrogen washout FRC for the nine subjects was 
2.1 ± 0.66 L (range 1.4 to 3.2 L). Mean age was 56 ± 15. Mean weight was 87.6 ± 25.2 
kg. Mean set baseline FIO2 was 0.42 ± 0.05. 
The Bland-Altman plot in Figure 5.4 shows the analysis of agreement between the 
CO2 FRC measurements and the reference method, nitrogen washout FRC, in nine 
mechanically ventilated ICU patients. The bias (CO2 - N2 washout) was -0.02 L with 
precision (1 SD of the error) of 0.26 L (-1.1 ± 12.6 % of N2 washout) and 95% limits of 
agreement of -0.54 to 0.49 L (-27.7 to 23.6 % of N2 washout). Linear regression analysis 
of CO2 and N2 washout FRC revealed R2 of 0.86 and slope of 0.74. 
 
5.5 Discussion 
The CO2 rebreathing FRC measurement system showed clinically acceptable 
accuracy (mean error) and precision (1 SD of the error) compared to both body 
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Figure 5.4: Bland-Altman plot comparing agreement between the functional 
residual capacity evaluated by CO2 rebreathing and nitrogen washout. The dashed line 
indicates mean bias, and the dotted lines mark the 95% limits of agreement. PC was 






%)) and nitrogen washout FRC in intensive care patients (accuracy -0.02 L, precision 
0.26 L (-1.1 ± 12.6 %)) with stable ventilation. 
In comparison, the GE nitrogen washout FRC method, which is currently 
marketed as an add-on for the GE CareStation ventilators, has been reported to have 
accuracy (mean bias) of 15% and one standard deviation of the error of 18% compared to 
CT in mechanically ventilated patients under controlled mechanical ventilation [21]. 
Compared to body plethysmography, the LUFU system described by Heinze and 
colleagues showed a bias of 2.6% and one standard deviation of the error of 13.1% [22]. 
For mechanically ventilated patients under controlled mechanical ventilation, the mean 
bias was -1.3% and one standard deviation of the error was 8.5% compared to Helium 
dilution [23]. Repeatability for the LUFU system showed a bias of 1.1% and one standard 
deviation of 10.8% in volunteers [24]. 
The automated bedside FRC measurement system is based on the CO2 washout 
signals obtained at the end of a partial CO2 rebreathing period. Gedeon and colleagues 
first proposed a CO2-based method for measuring FRC and cardiac output, implemented 
by using a short breath hold to perturb the gas exchange conditions in the lung [25]. The 
NICO2 cardiopulmonary monitor (Philips-Respironics, Wallingford, CT) was developed 
to apply the same (Fick) principle for cardiac output measurement during mechanical 
ventilation. In contrast to the breath hold proposed by Gedeon, however, the NICO2 
automated cardiac output measurement employs a 35-second partial CO2 rebreathing 
period to perturb the gas exchange conditions. The NICO2 monitor does not currently 
perform FRC measurement. Our data support Gedeon’s suggestion that it is possible to 




end of the partial rebreathing period. It may be possible for a single, non-invasive 
rebreathing method to automatically and continually quantify both cardiac output and 
FRC at the bedside during mechanical ventilation. Furthermore, the simultaneous cardiac 
output assessment can be used in the equations to improve accuracy in calculating FRC, 
as they were in this study. 
The CO2 rebreathing FRC measurement can be readily performed at any level of 
inspired fraction of oxygen (FIO2), and since it does not require a step change in FIO2 for 
measurement completion, it can be used for patients with high baseline FIO2 and for 
patients ventilated using a circle system where a step change in FIO2 is impossible. There 
may also be clinical value in knowledge of how the FRC has changed over a long period 
of time, such as hours or days; an automated monitor could provide averaged trending 
information. Of course, further studies are needed to establish the clinical utility of FRC 
measurement trends. 
The CO2 rebreathing method is sensitive to noise caused by instability in 
respiratory rate and tidal volume. A high coefficient of variation in tidal volume (i.e. 
greater than 15%) results in less accurate FRC measurements. CO2 is highly soluble in 
lung and blood tissue, and a greater than 15% change in tidal volume from one breath to 
the next changes the assumption of stable CO2 tissue solubility during the measurement 
period. Likewise, if the cardiac output increases or decreases more than 50% without 
being accounted for, the FRC will be overestimated/underestimated due to the high 
solubility of CO2 in blood. Therefore, the CO2 rebreathing method is most reliable when 
cardiac output and ventilation are stable, such as during controlled mechanical ventilation 




If the technique were automated, individual measurements could be completed 
until four FRC determinations with low coefficient of variation of tidal volume (< 10%) 
were available for inclusion in the average value. The requirement of stable tidal 
ventilation arises from the determination of FRC being based on a single breath of CO2 
washout. Repeating the FRC measurement until measured values are within a small range 
of variation is not without precedence since the AARC clinical practice guideline 
recommends taking multiple N2 FRC determinations, with at least 2 trials agreeing within 
10% of the mean[19]. The COV measurement threshold is a convenient method for an 
automated system to accomplish a similar goal. 
The CO2 rebreathing FRC method is likely best suited for patients under 
controlled mechanical ventilation, such as general anesthesia patients ventilated with 
circle breathing system or intensive care patients under controlled mechanical ventilation, 
both of which would likely display stable ventilation volume of < 10% COV. For this 
study, it was not possible to use nitrogen washout FRC as a reference with the circle 
breathing system (step change in oxygen is not possible), so we turned to volunteers and 
ICU patients for data collection. We choose to use body plethysmography and N2 
washout FRC methods as the gold standard methods for ambulatory subjects and 
intubated subjects, respectively. The drawback of studying patients with spontaneous or 
pressure controlled mechanical ventilation in place of controlled mechanical ventilation is 
that the tidal volume can be highly variable (typically 25-50% in this study), which 
increases the signal-to-noise ratio of the CO2 FRC measurement. We aimed to analyze 
only the FRC measurements collected during periods of stable tidal ventilation (COV < 




controlled mechanical ventilation. However, analysis of the volunteer data with this 
threshold yielded too few points for analysis. Therefore, we were forced to increase the 
COV threshold for the volunteer data to COV < 13%, which yielded eight subjects for 
statistical analysis. 
Our results were obtained from a small data set. If FRC results are analyzed from 
all subjects, the limits of agreement are higher, as expected due to the higher signal-to-
noise ratio resulting from variable tidal volume with spontaneous ventilation. Analysis of 
the results for all eighteen volunteer subjects for whom four individual measurements 
were available, including the subjects with coefficient of variation of tidal volume of up 
to 0.6, resulted in accuracy (mean bias) of -0.14 L with precision (1 SD of the error) of 
0.72 L (-3.9 ± 19.9 % of body plethysmography) and 95% limits of agreement of -1.55 to 
1.27 L (-43.0 to 35.1 %). Analysis of the results for all 14 ICU patients for whom four 
individual measurements were available, including the patients with coefficient of 
variation of tidal volume of up to 0.4, resulted in accuracy of -0.18 L with precision of 
0.69 L (-7.9 ± 29.8 % of N2 washout) and 95% limits of agreement of -1.15 to 1.17 L (-
66.3 to 50.5 %). 
Further research is necessary to understand how accurate, precise, and repeatable 
the method is for a larger group of patients including those with lung injury and V/Q 
mismatch. The FRC measured by the CO2 rebreathing method is reflective of the most 
accessible compartment of the ventilated lung, and as such, does not measure poorly 
ventilated areas where gas does not mix with each breath. Therefore, some 
underestimation in FRC will be due to not accounting for the poorly ventilated lung 




measuring the poorly ventilated portion of the FRC, a 5-min nitrogen washout method 
may be a better choice. 
In conclusion, we have shown that CO2 rebreathing FRC can be accurately 
measured during stable ventilation, as assessed by comparison with body 
plethysmography and nitrogen washout FRC. The CO2 rebreathing method is a good 
candidate for automated, long-term monitoring of trends in FRC during mechanical 
ventilation, even when a circle breathing system or high inspired oxygen fraction are 
used. Further research is needed to evaluate the accuracy compared to reference methods 
in a larger group of patients and during mechanical ventilation for patients with 
respiratory insufficiency and acute lung injury. 
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This dissertation develops and tests two novel methods for automated bedside 
functional residual capacity (FRC) measurement. The methods were developed in 
parallel, with each one based on a different tracer gas: nitrogen and carbon dioxide. 
Feasibility testing was performed with mechanically ventilated animals. Clinical 
evaluation was conducted with both healthy volunteers and intensive care patients treated 
with mechanical ventilation. 
The first method, modified multiple breath nitrogen washout, is based on a model 
of the lung that describes the volume-to-ventilation distribution of several compartments 
within the lung. The inputs for the model are the initial alveolar nitrogen concentration 
and breath-by-breath measurements of alveolar tidal volume. In contrast with the 
previously described volume-based nitrogen washout methods, this method relies on end-
tidal nitrogen concentration to measure FRC. The end-tidal nitrogen concentration 
measurements are used to estimate alveolar nitrogen concentration. When the model 
parameters are tuned correctly, the modeled breath-by-breath estimates of the alveolar 
nitrogen concentration are a good estimate of the measured values of alveolar nitrogen 
concentration observed throughout a washout period. The use of end-tidal concentration 
measurements rather than nitrogen volume measurements makes the method reliable even 
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during spontaneous and assisted mechanical ventilation, during which the ventilation 
pattern, tidal volume, and airway pressure are often highly irregular. Using end-tidal 
measurements, not volume, reduces errors from signal synchronization. In contrast, 
volume-based FRC measurement methods are typically less precise during irregular 
ventilation, and have been shown to have more than twice the standard deviation of the 
error of the end-tidal system compared to body plethysmography. Unlike the volume-
based methods, the end-tidal method can be accurately used at high inspired oxygen 
fraction (greater than 0.65) because it is not subject to errors introduced by Haldane 
transformation or assumed respiratory quotient of 0.85. Our novel, automatable, bedside 
method is compatible with any mechanical ventilator capable of quickly altering the 
inspired oxygen fraction.  
In volunteer testing, we compared the modified multiple breath nitrogen washout 
FRC model to the gold standard body plethysmography FRC measurement system and 
found a mean difference of -0.1%, standard deviation of the differences of 5.9%, and 
95% limits of agreement of -11.7 to 11.5% of body plethysmography. The 95% limits of 
agreement were improved compared to other methods tested under similar circumstances. 
A gold standard method was not available for accuracy testing during mechanical 
ventilation, so we chose to do repeatability testing in intensive care patients. The mean 
difference between repeated measurements was 0.4 ± 6.4% (mean ± standard deviation).  
The second method proposed in this dissertation for FRC measurement makes use 
of carbon dioxide as the tracer gas. The carbon dioxide-based FRC measurement 
analyzes the single-breath transition from steady state partial rebreathing to non-
rebreathing, making provisions for the high solubility of the gas in the body and the 
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variability in CO2 uptake due to changes in cardiac output. The signals required for the 
carbon dioxide rebreathing FRC measurement can be recorded using an on-airway 
volumetric capnometer. In this research work, we made use of the NICO2 non-invasive 
cardiac output monitor (Philips Medical, Wallingford, CT), which provided the breath-
by-breath signals necessary for the FRC measurement and automatically initiated a 35-
second partial CO2 rebreathing period once every 3 min. The automated, portable and 
simple nature of the monitor provides a convenient bedside system that can take 
continual FRC measurements during mechanical ventilation over hours or days. 
Furthermore, the CO2-based method is compatible with circle breathing systems, many 
anesthetic vapors, and patients ventilated with a high fraction of inspired oxygen who 
cannot tolerate change in inspired oxygen. Cardiac output, SpO2, airway resistance, lung 
compliance, and pressure-volume loops are additional parameters simultaneously 
provided by the non-invasive NICO2 monitor, which are useful together during titration 
of positive end-expiratory pressure and other mechanical ventilator settings. 
In volunteer testing, we compared the CO2 partial rebreathing FRC measurement 
to the gold standard body plethysmography and found a mean difference of 0.4%, 
standard deviation of the differences of 7.0%, and 95% limits of agreement of -13.4 to 
14.2% of body plethysmography,. During mechanical ventilation for intensive care 
patients, the mean difference between the CO2-based FRC and the nitrogen washout FRC 
was -2.6 ± 17.5% (mean ± standard deviation). The small signal-to-noise ratio of the CO2 







This work advances two methods for accurate, automated bedside FRC 
measurement during mechanical ventilation, with each method demonstrating advantages 
in different settings. The novel multiple breath nitrogen washout FRC measurement 
model demonstrates particularly good measurement precision, even during variable 
ventilation patterns. The CO2 partial rebreathing FRC measurement model is a good 
candidate for trending measurements in the operating room or intensive care unit without 
requiring a change in inspired oxygen for a measurement. Both FRC measurement 
methods are compatible with any ventilator brand and can easily be moved from patient 
to patient as desired for bedside measurement. 
With these simple-to-use FRC measurement methods, clinicians can take more 
frequent bedside FRC measurements, establish reference and normal FRC values for 
different patients and diagnoses, develop clinical guidelines for individualized treatment, 
monitor changes in a patient’s FRC with evolution of or recovery from disease, rule out 
reduced FRC as a cause of hypoxemia and recommend informed mechanical ventilator 
setting changes. Bedside FRC measurements are therefore a critical parameter that may 
be used in conjunction with other parameters such as lung compliance and PaO2. future 
studies using these nitrogen- and carbon dioxide-based FRC measurement methods with 
improved measurement availability and accuracy may show a clinical benefit of more 
closely monitoring FRC. More widespread use of automated bedside FRC measurement 
may support investigation of broader clinical answers to questions such as the 
relationship between FRC and disease progression, the rate and extent of alveolar 
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recruitment after applying PEEP, the effect of fluid balance, and the relationship between 




While the clinical studies demonstrated acceptably good accuracy, precision and 
repeatability for both tracer gas models for FRC measurement, they were limited by 
several factors. First, the data collected for this work is from a relatively small number of 
subjects. More data should to be collected to examine the accuracy in a wider range of 
subjects. Second, there is no clinical gold standard for FRC measurement during 
mechanical ventilation. Therefore, we chose to assess accuracy compared to body 
plethysmography in ambulatory volunteers and repeatability of measurement during 
mechanical ventilation. Third, the local institutional review board did not permit FRC 
measurement for intensive care patients who required more than 5 cm H2O of positive 
end-expiratory pressure (PEEP) during baseline mechanical ventilation. This limitation in 
the patient pool led to testing of the healthiest among the patients in the intensive care 
unit. Therefore, accuracy during significant lung injury remains a question for future 
research.  
 
6.4 Future Work 
 
These first clinical studies of the modified multiple breath nitrogen washout FRC 
model indicate the model has great potential for reliable for bedside use. Of course, the 
model should be evaluated in a larger number of patients to confirm the results before the 
FRC measurement can be routinely applied at the bedside to guide treatment. It would be 
valuable as a next step to conduct an additional clinical evaluation for the modified 
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multiple breath nitrogen washout FRC model with respect to accuracy for intensive care 
patients with significant lung injury and subsequent to changes in positive end-expiratory 
pressure. Possible reference methods for clinical evaluation during mechanical ventilation 
include helium dilution or computed tomography.  
The modified multiple breath nitrogen washout method may potentially be further 
simplified to exclusively analyze the oxygen signal since carbon dioxide excretion is 
typically stable during the washout period and therefore does not contribute significantly 
to the FRC measurement accuracy. In essence, a simplified model would predict the 
multiple breath oxygen wash-in or washout signal compared to the alveolar concentration 
observed as end-tidal oxygen fraction. Such an analysis could be carried out, at least 
preliminarily, using the data already collected for this dissertation. It may also be of 
interest to assess the accuracy of FRC measurements using a smaller step change in 
inspired oxygen to initiate the washout. 
The CO2 partial rebreathing FRC measurement requires additional clinical 
assessment with a larger number of patients before it can be applied at the bedside to 
guide treatment. Of particular interest for future work is the accuracy of the method 
during controlled mechanical ventilation for patients with lung injury. Future testing is 
also warranted to determine the number of measurements required for the average FRC 
value when the ventilation pattern is variable. 
